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Axonal integrity and longevity require functionally intact myelin, as demonstrated by the 
deletion of myelin-specific genes in mice. To identify molecules that contribute to the 
structural organization of CNS myelin, its protein content was systematically analyzed by 
quantitative proteome analysis. It was found that filament-forming septins are surprisingly 
abundant in myelin and we hypothesized that septin filaments may constitute a 
cytoskeletal membrane cortex. Here, I have investigated the exact subcellular localization 
and the pathobiological relevance of the septin cytoskeleton in myelinating glial cells. By 
immunohistochemistry, myelin septins were found to specify a novel subdomain in the 
internodal adaxonal compartment of CNS myelin, in which they assemble as filamentous 
structures gently undulating along the internodal segment of axons. Targeted deletion of 
the Sept8-gene, which encodes the most abundant myelin septin, led to secondary 
diminishment of SEPT2, SEPT4, SEPT7 and SEPT9 in myelin. SEPT8 is thus essential 
for the assembly of the CNS myelin septin filament. By quantitative mass spectrometry, 
the septin-polymerizing protein anillin was also diminished in SEPT8-deficient myelin, 
demonstrating a reverse effect of septins on anillin. Importantly, the targeted loss of 
SEPT8 and its associated proteins led to pathological outfoldings of myelin, indicating for 
the first time that the myelin septin filament prevents the emergence of this very specific 
pathology. Interestingly, myelin outfoldings alone did not induce axonal pathology or 
neuroinflammation. Only when further challenged, e.g. by a reduced abundance of the 
myelin protein CNP or the induction of EAE, the altered myelin structure triggered 
enhanced neuroinflammation. I have also approached the septin cytoskeleton of 
peripheral myelin. Interestingly, in Schwann cells, the subunit composition of septin 
filaments partly differs from that of CNS myelin and septins localize to the abaxonal 
compartment of peripheral myelin termed the bands of Cajal. The targeted deletion of 
SEPT8 did not lead to a loss of the PNS myelin septin filament, most likely because of a 
compensatory increase in the abundance of the closely related SEPT11. Together, septin 







2.1. Cells of the nervous system 
Multicellular organisms have evolved over 500 million years ago, when cells that 
cooperated with others gained an evolutionary advantage. These associations were the 
basis for the evolution of a variety of species. Highly specific cell types evolved, which 
formed complex tissues, such as in the nervous system. In species of both, the 
protostomia and the deuterostomia clade, neurons interconnect and provide the capacity 
to control behavior and to store memories (Alberts, 2002). Glial cells, a group of non-
neuronal cell types in the nervous system, are believed to support neuronal functions 
(Kettenmann and Ransom, 2005). 
In the mammalian central nervous system (CNS), glial cells are subdivided in astrocytes, 
oligodendrocytes, and microglia (Kettenmann and Ransom, 2005). Astrocytes were 
shown to support neurons by transferring nutrients, e.g. lactate, and by discarding 
neurotransmitters from the synaptic cleft (Kettenmann and Ransom, 2005). Microglia 
originate from the immune system. They remove cell debris and have partially supportive 
functions in phases of cell stress and regeneration (Kettenmann and Ransom, 2005, 
Ransohoff and Cardona, 2010). Oligodendrocytes form very long processes and wrap 
them closely around axonal segments. By insulating axons at the internodes and thereby 
restricting action potentials to the nodes of Ranvier, they are the basis for fast saltatory 
nerve conduction (Baumann and Pham-Dinh, 2001, Kettenmann and Ransom, 2005). 
Similar to oligodendrocytes in the CNS, Schwann cells myelinate axons in the peripheral 
nervous system (PNS) and are thus essential for fast signal propagation as well (Jessen 
and Mirsky, 2005, Kettenmann and Ransom, 2005). 
 
2.2. Assembly and structural organization of myelin  
Oligodendrocytes and Schwann cells differ regarding their structural organization and their 
mechanisms to achieve myelination (Fig. 1A). Oligodendrocytes are multipolar cells and 
form several processes, which myelinate many axonal segments. In contrast, Schwann 
cells are bipolar cells and enwrap only one axonal segment each. In both cases, myelin is 
a specialized, vital compartment of the cell, which can further be subdivided in compact 
and non-compact myelin (Arroyo and Scherer, 2000, Poliak and Peles, 2003). Compact 
myelin consists of several layers of plasma membrane, which are adhesive. In particular, 
myelin basic protein (MBP) was shown to be an essential adhesion protein in the CNS 
myelin while in the PNS myelin protein zero (MPZ, P0) contributes additionally (Dupouey 





of these adhesion proteins, consists of adaxonal myelin, abaxonal myelin, incisures and 
paranodal loops (PL), differently organized in CNS and PNS (Fig. 1B). These domains, 
contrary to compact myelin, contain cytoskeletal elements and cytoplasm. (Arroyo and 
Scherer, 2000, Poliak and Peles, 2003). 
 
 
Fig. 1. Structure of myelinated axons. A Oligodendrocytes and Schwann cells form myelin of 
different structural organization. Oligodendrocytes cover multiple axonal segments whereas 
Schwann cells cover only one. Nonetheless, both provide the basis for saltatory signal propagation. 
B Myelin is a complex structural specialization of the cell consisting of compact and non-compact 
myelin. Myelination of an axon leads to the longitudinal molecular and structural specialization of 
axonal segments: internode, juxtaparanode (JXP), paranode and node (Poliak and Peles, 2003) 
(adapted image from Poliak and Peles, 2003). 
 
Glial and axonal membranes are tightly connected and depend on each other (Fig. 1B). 
For instance, the paranodal loops form septate-like junctions (SpJ) with the axon and 
were shown to directly influence the distribution of sodium channels at the node of Ravier 
and potassium channels at the juxtaparanode (JXP) (Poliak and Peles, 2003, Rasband, 
2011). Furthermore, the adaxonal membranes cover a large proportion of the axon at the 
juxtaparanodes and the internodes, therefore excluding other cellular interactions. The 
hypothesis was raised that intercellular exchange with oligodendrocytes supports axonal 
functions e.g. by release of monocarboxylates or exosomes (Kramer-Albers et al., 2007, 
Rinholm et al., 2011). Therefore, the adaxonal internodal compartment of myelin appears 
suitable. Recently, it was demonstrated that trophic support by oligodendrocytes is indeed 
of relevance for the long-term integrity of neurons (Nave, 2010, Funfschilling et al., 2012, 







Fig. 2. Oligodendroglial complexity. To visualize the compact and the non-compact 
compartments of myelin, an oligodendroglial process was schematically unwrapped. Cytosolic 
channels in the myelin sheath demonstrate the specialization of oligodendroglial processes. 
Regulated transport of molecules takes place along these channels (Brahic and Roussarie, 2009) 
(adapted image taken from Brahic and Roussarie, 2009). 
 
Complex molecular mechanisms underlie the transport of molecules to the outermost 
adaxonal myelin compartment (Fig. 2). By electron microscopy, microtubules and 
multivesicular bodies were visualized within adaxonal myelin disclosing the existing 
pathways in non-compact myelin (Mobius et al., 2010). For instance, mRNA encoding 
MBP was shown to be transported into the periphery of the myelinating cells and 
translated locally (Colman et al., 1982). Interestingly, other cytoskeletal elements such as 
actin and intermediary filaments are diminished in and may even be absent from mature 
myelin (Wilson and Brophy, 1989, Richter-Landsberg, 2001, Jahn et al., 2013).  
Taken together, oligodendrocytes form complex cellular processes with a highly 
specialized molecular composition to enwrap axons for fast nerve conduction velocity and 
for axonal support. However, knowledge of the molecular basis for these processes has 






2.3. Axonal pathology related to oligodendroglial dysfunction 
Dysfunction of oligodendrocytes has secondary consequences for the integrity of axons. 
The analysis of mouse mutants lacking the expression of particular myelin proteins has 
demonstrated the relevance of a functional glia-axonal association. In particular, when 
genes encoding for proteolipid protein (PLP), a protein of compact myelin, or 2'3'-cyclic 
nucleotide 3'phosphodiesterase (CNP), a protein of non-compact myelin, were deleted in 
mice, oligodendrocytes were able to form myelin. However, unexpected at that time, 
axonal degeneration was observed (Klugmann et al., 1997, Griffiths et al., 1998, Lappe-
Siefke et al., 2003). 
The structural changes of the axon-myelin unit in both mutants were closely analyzed. In 
mice lacking the expression of PLP, myelin has been reported to also lack the adhesive 
radial component, which may contribute to incomplete compaction of myelin layers 
(Rosenbluth et al., 2006). However, there is no published evidence of PLP itself having 
adhesive properties. The presence of loose myelin layers observed in some reports may 
be the result of poor fixation (Mobius et al., 2008). Furthermore, an increased number of 
small non-myelinated axons has been identified, demonstrating a moderate delay in 
myelin biogenesis when PLP is lacking (Yool et al., 2001). It was recently shown that the 
association of PLP with cholesterol, an abundant myelin lipid, together with the related 
proteolipid GPM6B might be important for the trafficking of prospective myelin membrane 
during in myelin biogenesis (Werner et al., 2013). In addition, the axonal transport was 
found to be impaired (Edgar et al., 2004). In mice lacking the expression of CNP, 
swellings affecting the inner (non-compacted) layer of myelin (adaxonal myelin) have 
been observed (Edgar et al., 2009), possibly reflecting the disability to establish a balance 
between import and export of molecules. Interestingly, it was reported that CNP-deficiency 
leads to decreased process outgrowth of cultured oligodendrocytes by affecting tubulin 
polymerization (Lee et al., 2005). This suggests a mechanism according to which an 
impaired transport through the channels of non-compact adaxonal myelin may be involved 
in the emergence of axonal pathology. Additionally, axonal proteins, such as sodium 
channels at the nodes of Ranvier and Caspr at the paranodes, were reported to be 
mislocalized in the optic nerve of CNP-deficient mice upon aging, also suggesting 
impaired axon-glia interactions (Rasband et al., 2005).  
Yet, a common molecular pathway, which could have elucidated the mechanism on how 
oligodendrocytes support the integrity of axons, has not been identified. Mice lacking both, 
PLP and CNP, displayed enhanced axonal pathology, suggesting at least two coexisting 
(possibly overlapping) pathways (Edgar et al., 2009). Thus, the molecular basis for the 





interest, since the prevention of axonal degeneration is one challenge to achieve healthy 
longevity. 
 
2.4. Relevance of myelin thickness and integrity  
The process of myelination is tightly regulated. Axonal signals that regulate myelin 
thickness include neuregulin in the PNS, while responsible molecules are still elusive in 
the CNS (Michailov et al., 2004, Brinkmann et al., 2008). However, several molecular 
pathways contributing to myelin thickness intrinsic to oligodendrocytes have been 
identified.  
The amount of myelin is measured by dividing the axonal by the myelin diameter (g-ratio). 
Amazingly, the ratio is constantly between 0.6 and 0.8, optimal for signal propagation 
(Hildebrand and Hahn, 1978, Chomiak and Hu, 2009). The analysis of several mouse 
mutants has demonstrated that the maintenance of myelin thickness is crucial. For 
instance, the targeted loss of PTEN from oligodendrocytes, a negatively regulator of the 
mTOR pathway, led to an increase of myelin gene expression and enhanced myelin 
thickness (Goebbels et al., 2010). These mice live only up to 4 months, which has 
suggested that increased myelin thickness myelin is a disadvantage. Furthermore, these 
mice develop a pathologically abnormal myelin structures (myelin outfoldings). Hence, 
myelin integrity might influence axonal health additionally to the proposed trophic support. 
In similarity, pathological outfoldings of myelin have been observed when the gene 
encoding CDC42 was deleted though without alterations of myelin thickness (Thurnherr et 
al., 2006). CDC42 is a Rho-GTPase involved in several regulatory pathways, which 
prevented the identification of the responsible downstream effectors. Nevertheless, this 
observation has provided evidence that various pathways contribute to the prevention of 
pathological myelin outfoldings.  
 
2.5. Septins 
In myelin of the central and the peripheral nervous system, several members of the septin 
protein family were recently identified as abundant components (Buser et al., 2009, Patzig 
et al., 2011). The interest in these novel myelin proteins has been accelerated by the 
finding that a number of septins were reduced in PLP-deficient CNS myelin, and in myelin 
lacking the lipid-modifying enzyme CGT (Werner et al., 2007, Fewou et al., 2010). 






Septins are GTP-binding proteins expressed in all eukaryote clades except plants (Pan et 
al., 2007, Hall et al., 2008). They were first discovered in yeast as essential for cell 
division (Hartwell, 1971). Depending on GTP-binding, septin monomers polymerize to 
form hetero-oligomers and can further assemble into higher order structures, such as 
rings or filaments (Mendoza et al., 2002, Oh and Bi, 2011). The latter were first described 
as filaments of 10 nm diameter located at the point of septation between mother and 
daughter cell of Saccharomyces cerevisiae, according to which they were named septins 
(Byers and Goetsch, 1976, Haarer and Pringle, 1987, Hall and Russell, 2012).  
13 septin genes (with several splice variants) exist in mice and humans, namely Sept1-
Sept12 and Sept14 (Macara et al., 2002, Cao et al., 2007). The human Sept13 has 
recently been confirmed as a pseudogene of Sept7 (HGNC: 32339). Additional to being 
partially important in cell division (Hall and Russell, 2004, Kremer et al., 2007, Fuchtbauer 
et al., 2011), mammalian septins have been shown to act as scaffold proteins and 
diffusion barriers in various cell types (Hall and Russell, 2012, Spiliotis and Gladfelter, 
2012). Based on their capacity to form filaments, their interaction with tubulin and actin in 
at least some systems, and their influence on cell morphology, septins are believed to 
constitute a fourth type of cytoskeleton (Mostowy and Cossart, 2012). 
Mammalian septins are subdivided in four groups according to their sequence homology 
(Macara et al., 2002, Kinoshita, 2003). Their interactions have been studied extensively, 
and it emerged that within a hetero-oligomer, septins of different homology groups 
interconnect in a molar 1:1:1 ratio (Kinoshita, 2003). For example, an oligomer consisting 
of SEPT2, SEPT6, and SEPT7 has been shown to assemble into filaments in vitro, and its 
crystal structure was revealed (Sheffield et al., 2003, Low and Macara, 2006, Sirajuddin et 
al., 2007). By interacting with membrane lipids, the hetero-oligomers further polymerize 
and form a meshwork, in some respects similar to the actin cytoskeleton, but of 
considerable rigidity due to comparably low dynamics. Considering their association with 
plasma membranes, the stabilization of membranes has been suggested as one major 
function of septin filaments (Tanaka-Takiguchi et al., 2009, Gilden and Krummel, 2010).  
 
2.6. Septin functions in post-mitotic mammalian cells 
Septins have been shown to have various functions in post-mitotic cells. By knock-
down/overexpression experiments in vitro or by deletion in vivo, the biology of septins in 
mammalian cells has been studied. These analyses demonstrate features, which might 
also apply to myelin septins. For instance, when the gene encoding SEPT4 was 





morphological changes of sperm cells (Kissel et al., 2005). SEPT4, likely required as a 
central monomer of a filament, was shown to localize to the annulus of the sperm cell 
thereby separating head and tail. Upon the loss of SEPT4, separation did not occur. 
Hence, it was shown that septins perform a function as a diffusion barrier for membrane 
domains (Kwitny et al., 2010). Similar findings regarding septin function as a diffusion 
barrier have been shown for cilia (Hu et al., 2010). 
The gene encoding SEPT5 was deleted in mice to define the function of septins in 
neurons (Peng et al., 2002). These mice developed largely normal though changes in the 
abundance of other septin have been shown in a preparation of synaptic vesicles. This 
has suggested a possible redundancy of closely homologous septins. However, the 
targeted deletion of both SEPT3 and SEPT5 has not led to a measurable effect on the 
development of hippocampal neurons (Tsang et al., 2011). Nevertheless, further studies 
of SEPT5 exposed alterations in the early development of synapses in vivo. It was 
revealed that indeed SEPT5 influences docking of synaptic vesicles, at least in immature 
presynapses (Yang et al., 2010). It has been postulated that a meshwork of SEPT5-
containing filaments covers the cytosolic surface of the presynaptic membrane and 
thereby reduces docking events. Therefore, it has been suggested that septins might also 
affect the transport and fusion of vesicles in other cells (Gilden and Krummel, 2010).  
Septins have also been shown as abundant in dendritic spines (Tada et al., 2007, Xie et 
al., 2007). For example, the number of protrusions on dendrites and the size of dendritic 
spines were altered by knockdown or forced expression of SEPT7. This has suggested 
that membrane rigidity is influenced by septins in dendrites, and that their deletion leads to 
a decrease of protrusions and to a larger number of immature spines.  
In similarity, membrane rigidity is influenced by septins in cultured amoeboid T-cells. 
Knockdown of SEPT7, and consequently of the SEPT7-containing septin filament, led to 
increased uropod length, correlating with diminished membrane rigidity (Tooley et al., 
2009). Additionally, the presence of septin filaments was associated with decreased 
membrane flexibility (Gilden et al., 2012). 
In summary, several functions of septins have been shown in post-mitotic cells. In 
particular, the capacity to enhance membrane rigidity appears of relevance for a 
cytoskeletal element in the myelin sheath. Nevertheless, functions such as a diffusion 
barrier or in vesicle transport are also conceivable. The functional relevance of the septin 






2.7. Inflammation in the central nervous system 
Microglia are the main cell type of the innate immune system of brain and spinal cord 
(Rivest, 2009, Ransohoff and Cardona, 2010). They are widely distributed in the CNS and 
were shown to dynamically explore their tissue environment (Nimmerjahn et al., 2005). In 
models of myelin dysfunction with axonal pathology, the immune system of the CNS is 
‘activated’. Upon activation, microglia proliferate, their morphology changes and they start 
to express marker genes of macrophages (Ransohoff and Brown, 2012). The underlying 
mechanisms and the role in pathological situations are under intense investigation.  
Several scenarios of microglial activation have been described (Rivest, 2009). Alterations 
affecting myelin or signals presented by oligodendrocytes might directly trigger microglial 
activation. For instance, it was shown that vesicles containing myelin proteins are taken 
up by microglia (Fitzner et al., 2011). Therefore, impairment of oligodendrocyte-derived 
signals might well affect the fate of microglia. Furthermore, myelin and myelin proteins are 
able to trigger immune responses (Pinteaux-Jones et al., 2008). Hence, axonal 
degeneration could result from chronic microglial activation (Fig. 3). Thus, removal of 
myelin debris is required for normal brain development and might be beneficial in several 
diseases (Yong and Rivest, 2009).  
One the other hand, stressed axons can activate microglia. For instance, ATP and 
glutamate release by axons causes microglial activation. This leads to the release of 
TNFα, which has been shown to be protective for neurons (Lambertsen et al., 2009). 
Furthermore, amyloid precursor protein (APP) accumulations in axons are processed and 
internalized by microglia. Continuous impairment affecting axonal transport and therefore 
the accumulation of APP might lead to constant pro-inflammatory cues (Rivest, 2009). 
Taken together, it has remained speculative if the deletion of oligodendroglial proteins or 







Fig. 3. Dual nature of the immune response in the central nervous system. Microglia respond 
to several extracellular cues. The resulting activation may be either beneficial or detrimental for 
axonal survival. Removal of cell debris and release of TLR4 or TNF by microglia support 
regeneration. In contrast, chronic or false activation can lead to axonal degeneration (Rivest, 2009) 





2.8. Aim of the study 
Several proteins of the septin family have recently been identified as abundant 
constituents of myelin. Also considering prior knowledge about the biology of septins in 
other cell types, we have hypothesized that septins are relevant for the biogenesis or 
maintenance of myelin. The aim of this study is thus to uncover the function of myelin 
septins in vivo, in particular in the central nervous system. The relevance of this analysis 
has been triggered by the 2D-DIGE-based finding that the abundance of myelin septins is 
decreased in myelin of the PLP-deficient mouse model with secondary axonal pathology. 
These findings are to be validated using gel-free, quantitative mass spectrometry and 
compared to myelin of CNP-deficient mice, which also exhibit secondary axonal 
pathology. As a basis for understanding the function of myelin septins, their exact 
localization is to be visualized by immunohistochemistry and immunoelectron microscopy. 
To test the functional requirement of myelin septins, SEPT8 is to be deleted in 
oligodendrocytes and Schwann cells of mice. Septins have been described to assemble 
as filaments. Therefore, secondary changes to the abundance of other septins upon the 
deletion of SEPT8 are of interest. Quantitative mass spectrometry is to be used to analyze 
systematically such changes in SEPT8-deficient myelin. Immunoblot analysis is to be 
used to validate eventual findings. This strategy will also allow the unbiased identification 
of possible interacting proteins dependent in their abundance on myelin septins. Equally 
important, the structural consequences of the absence of SEPT8 from myelin are to be 
analyzed in detail. As oligodendrocytes support axonal integrity, secondary pathologies 
are to be studied in SEPT8-deficient mouse brains by immunohistochemistry, including 
markers for axonal degeneration and for neuroinflammation. As oligodendrocytes and 
Schwann cells differ with respect to myelin structure and protein composition, the 
localization and the functional relevance of septins may differ between CNS and PNS 
myelin. Therefore, the localization of septins and the functional consequences of the 





3. Material and Methods 
3.1. Material 
3.1.1. Kits and chemicals 
All chemicals were purchased from Sigma-Aldrich GmbH (Munich, Germany), Merck 
KGaA (Darmstadt, Germany) and SERVA (Heidelberg, Germany) unless stated 
otherwise. General laboratory materials were from BD Falcon (Heidelberg, Germany), Bio-
rad (München, Germany) Gilson (Limburg-Offheim, Germany), Brand (Radebeul, 
Germany) and Eppendorf (Hamburg, Germany). 
Kits 
RNA purification ‘RNeasy mini prep’  Qiagen (Portland, USA) 
DC Protein Assay (Lowry) Bio-Rad (Munich, Germany)  
LSAB2 kit  Dako (Hamburg, Germany) 
Vector Elite ABC Kit Vector Labs (Loerrach, Germany) 
DAB Zytomed Kit  Zytomed Systems GmbH (Berlin, Germany) 
 
3.1.2. Molecular biology  
Modified Gitschier buffer (MGB) 
67 mM  Tris/HCl, pH 8.8 
16.6 mM  (NH4)2SO4 
6.5 mM  MgCl2 
0.5% [v/v] Triton X-100 
Proteinase K (10 mg/ml) 
Added to MGB buffer before use for tail digest 
Final concentration 1 mg/ml 
10 mM dNTP (50x stock) 
2.5 mM each nucleotide (dATP, dCTP, dGTP, dTTP) (Boehringer-Ingelheim, Germany) 
200 μM final concentration in a PCR reaction (50 μM each nucleotide) 
50x Trisacetate EDTA (TAE) buffer 
2.0 M  Tris/Acetate, pH 8.0 
50 mM  EDTA 







GOTaq DNA polymerase  Promega (Mannheim, Germany) 
Superscript III-reverse transcriptase Invitrogen (Karlsruhe, Germany) 
 
DNA marker 
GeneRuler 100 bp DNA ladder Thermo Scientific (St. Leon-Rot, 
Germany) 
 
3.1.3. Protein biochemistry buffers 
10x Phosphate buffered saline (PBS) 
1.7 M   NaCl 
34 mM  KCl 
40 mM  Na2HPO4 x 2H2O 
18 mM  K2HPO4 
pH 7.2 with 1N NaOH. 
10x Tris-buffered saline (TBS) 
500 mM   Tris/HCl, pH 7.5  
1.5 M   NaCl 
Modified RIPA buffer (protein lysis buffer) 
1x  TBS 
1 mM  EDTA 
0.5% [w/v] Sodium deoxycholate 
1.0% [v/v] Triton X-100 
Complete Mini protease inhibitor (Roche Diagnostics GmbH, Mannheim, Germany)  
1 tablet/10ml of RIPA buffer 
Protease inhibitor was added freshly to the RIPA buffer before use. 
 
3.1.4. SDS PAGE and immunoblot  
SDS separating gel 
12% or 10% [w/v] Acrylamid/ Bisacrylamid 29:1 
0.4 M  Tris/HCl pH 8.8 
0.1% [w/v] SDS 
0.03% [w/v] APS 






SDS stacking gel  
4% [w/v] Acrylamid/ Bisacrylamid 29:1 
125 mM  Tris/HCl pH 6.8 
0.1% [w/v] SDS 
0.05% [w/v] APS 
0.1% [v/v] TEMED 
4x SDS sample buffer 
40% [v/v] Glycerol  
240 mM  Tris/HCl pH 6.8  
8% [w/v] SDS  
0.04% [w/v]  Bromophenol blue 
10x SDS running buffer (Laemmli buffer)  
250 mM  Tris base 
1.92 M  Glycine 
1% [w/v] SDS 
Transfer buffer 
96 mM  Tris base 
78 mM  Glycine 
10% [v/v] Methanol 
20x Tris buffered saline (TBS) 
1 M  Tris/HCl, pH 7.4 
3 M  NaCl 
 
1x TBS with Tween-20 (TBST) 
50 mM  Tris/HCl, pH 7.5 
150 mM  NaCl 
0.05% [v/v] Tween-20 
Immunoblot stripping buffer 
0.2 M  Glycine/HCl, pH 2.5 
0.1% [v/v] Tween-20 
Immunoblot blocking buffer 
5% [w/v]  non-fat dry milk powder in 1x TBST 
Protein marker 







Enhanced Chemiluminescence (ECL) Immunoblot detection kit Western Lightning™ Plus-
ECL, Enhanced luminol reagent plus (Perkin Elmer Life Sciences, Inc., Rodgau, 
Germany). 
ECL-Hyperfilms (Amersham Biosciences, Uppsala, Sweden) 
PVDF membrane Hybond P pore size 0.45 μm (Amersham Biosciences, Uppsala, 
Sweden) 
 
3.1.5. Solutions for Fixation 
Avertin 
2% [w/v] 2,2,2 Tribromethanol 99% 
2% [v/v] Amylalkohol  
Mixed at 40°C for 30 min while stirring and subsequently filtered 
Stored at -20°C 
16% [w/v] Paraformaldehye (PFA) 
16% [w/v]  Paraformaldehyde cooked at 65°C for 20min while stirring  
5 N  NaOH droplets until solution was cleared and then filtered 
0.2M Phosphate buffer (fixation buffer) 
0.36% [w/v]  Sodiumdihydrogenphosphate (NaH2PO4) 
3.1% [w/v]  di-Sodiumhydrogenphosphate (Na2HPO4) 
1% [w/v] Sodium chloride  
 
4% [w/v]  Paraformaldehye (PFA, immunohistochemistry) 
4% [w/v]  PFA  
0.1 M  Phosphate buffer  
Karlsson-Schultz fixative (electron microscopy) 
4% [w/v]  PFA  
2.5% [v/v]  Glutaraldehyde  
0.1 M  Phosphate buffer  
Immuno Karlsson-Schultz fixative (immuno electron microscopy) 
4% [w/v]  PFA  
0.25% [v/v]  Glutaraldehyde  






3.1.6. Immunohistochemistry and staining solutions 
Phosphate buffer (0.2 M, pH 7.4) 
0.04 M  Sodiumdihydrogenphosphate (NaH2PO4) 
0.16 M  di-Sodiumhydrogenphosphate (Na2HPO4) 
Always prepared freshly 
Citrate buffer (0.01 M, pH 6.0) 
1.8 mM  Citric acid (C6H8O7.H2O) 
8.2 mM  Sodium citrate (C6H5O7Na3.2H2O) 
Always prepared freshly  
BSA/PBS  
0.04M  Sodiumdihydrogenphosphate (NaH2PO4) 
0.16M  di-Sodiumhydrogenphosphate (Na2HPO4) 
1.8% [w/v] Sodium chloride 
1.0% [w/v] Bovines serum albumin (BSA)  
Tris buffer (pH 7.6) 
50 mM Tris/HCl, pH 7.6 
0.9% [w/v] Sodium chloride (NaCl) 
Always prepared freshly. 
Mayer’s haematoxylin solution 
0.1% [w/v] Haematoxylin  
0.02% [w/v]  Sodium iodate  
5% [w/v]  Potassium aluminium sulphate (K2Al2(SO4)4.24H2O) 
Added under constant shaking, solution turned violet blue 
5% [w/v]  Chloralhydrate  
0.1% [w/v]  Citric acid added  
Added and filtered before use 
Eosin solution  
0.1% [v/v]  Eosin  
12 drops of glacial acetic acid in 250ml  
Scott’s solution 
0.2% [w/v]  Potassiumhydrogencarbonate 






HCl - alcohol 
0.09% [v/v] HCl  
70% [v/v] Ethanol 
 
β-Gal staining buffer  
5 mM  Potassium ferricyanid 
5 mM  Potassium ferrocyanid 
2 mM  MgCl2 
1.2 mg/ml 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-gal)  
Adjusted in 1x PBS 
Gallyas silver impregnation  
Incubation solution 
0.1% [w/v] Ammonium nitrate 
0.1% [w/v] Silver nitrate 
12‰ [w/v]  Sodium hydroxide (pH 7.5) 
Brown precipitate dissolved by shaking, stored for 8-10 weeks. 
Physical developer 
Solution A  5% [w/v]  Sodium carbonate (dehydrated) in H2O 
Solution B  0.2% [w/v] Ammonium nitrate 
 0.2% [w/v] Silver nitrate 
 1% [w/v] Wolframosilicic acid (silicotungstic acid) 
Solution C  0.2% [w/v] Ammonium nitrate 
 0.2% [w/v] Silver nitrate 
 1% [w/v] Wolframosilicic acid (silicotungstic acid) 
 0.26% [w/v]  Paraformaldehyde 
To reconstitute physical developer: 70ml of solution B added to 100ml of solution A with 
constant and gentle shaking and then slowly added to 1000ml solution C. 
Fixing solution  
2% [w/v] Sodium thiosulphate 
Blocking buffer for cryosections 
5% [v/v] Goat serum  
0.5% [v/v] Triton X-100 








Blocking buffer for teased fibers 
10% [v/v]  Horse serum  
0.1% [v/v] Tween-20  
Dissolved in 1x PBS 
Mounting media 
Eukitt Kindler (Freiburg, Germany) 
Aqua-Poly/Mount Polysciences (Eppelheim, Germany) 
 
3.1.7. Electron microscopy  
Epon 
Mixed 30 min before embedding in the following way: 
171.3 g  Glycidether 100 
115 g  DDSA (Dodecenyl succinic anhydride) 
89 g  MNA (Methyl nadic anhydride) 
Mixed using magnet stirrer for 10 min and then  
6.5 ml  DMP-30 
Added and mixed using magnet stirrer for 20 min 
 
Methylene blue - Azure II staining solution  
Methylene blue  
1% [w/v] Na-tetraborat (Borax)  
1% [w/v]  Methylenblau  
Azure II  
1% [w/v]  Azure II 










Antibody Species Dilution Purpose Vendor 
APP Monoclonal mouse 1:750 IHC Chemicon 
Caspr Monoclonal mouse 1:500 IHC Neuromabs 
CNP Monoclonal mouse 1:2000 IB Sigma 
FNP7 (pan 
neurofilament) 
Monoclonal mouse 1:500 IB Zymed Lab. Inc. 
Kv1.2 Monoclonal mouse 1:200 IHC Neuromabs 
Mac3 Monoclonal rat 1:500 IHC Pharmingen 
MAG (513) Monoclonal mouse 1:50 IHC Chemicon 
PLP(A431) Polyclonal rabbit 1:500 IB K.-A. Nave 
SEPT2 Polyclonal rabbit 1:500 IB 
Nicole Schaeren-
Wiemers 
SEPT4 Polyclonal rabbit 1:500 IB IBL 
SEPT7 Polyclonal rabbit 1:5000 IB IBL 
SEPT8 Polyclonal rabbit 1:2000 IB ProteinTechGroup 
SEPT8 Polyclonal rabbit 1:50 IEM ProteinTechGroup 
SEPT9 Polyclonal rabbit 1:1000 IB ProteinTechGroup 
SEPT9 Polyclonal rabbit 1:50 IEM ProteinTechGroup 
SEPT11 Polyclonal rabbit 1:1000 IB Koh-ichi Nagata 
Smi31 (NF) Monoclonal mouse 1:1000 IHC Covance 
α-tubulin  Monoclonal mouse 1:5000 IB Sigma 







Antibody Species Dilution Purpose Vendor 
α-rabbit-HRP Goat  1:10000 IB Dianova 
α-mouse-HRP Goat  1:10000 IB Dianova 
α-rat-biotinylated  Rabbit 1:100 IHC Vector 
α-rabbit-Alexa488 Donkey 1:1000 IHC Dianova 
α-rabbit-Cy3 Goat 1:500 IHC Dianova 
α-mouse-Cy3 Goat 1:500 IHC Dianova 
α-mouse-
Dyelight633 
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Oligonucleotides were synthesized by the service facility of the Max-Planck-Institute for 
Experimental Medicine. 
 
Genotyping primer for various mouse lines (internal numbers) 
Flp recombinase genotyping:  
15300: 5’- CAC TGA TAT TGT AAG TAG TTT GC -3' 
15301: 5’- CTA GTG CGA AGT AGT GAT CAG G -3' 
Sept8 genotyping: 
15048: 5’- CAACGGGTTCTTCTGTTAGTCC-3’ 
16458: 5’- CAGGCAGATGTATATGCAGCAG-3’ 
16459: 5’- GGTGGCTTTGAACTTGCTATCC-3’  
16460: 5’- GAAGCAGCCATAGAGGAGATCC-3’ 
Cre recombinase genotyping: 
2016: 5'- GCCTTCAAACTGTCCATCTC -3' 
4192: 5'- CAGGGTGTTATAAGCAATCCC -3' 
4193: 5'- CCTGGAAAATGCTTCTGTCCG -3' 
7315: 5'- CCCAGCCCTTTTATTACCAC -3' 
 
Quantitative real-time PCR primers 
Anln 
Forward: 5’- ACAATCCAAGGACAAACTTGC-3’ 
Reverse: 5’- GCGTTCCAGGAAAGGCTTA-3’  
 
Ppia 
Forward: 5’- CACAAACGGTTCCCAGTTTT -3’ 








Forward: 5’- TCCTGACTGATCTCTACCCAGAA-3’ 
Reverse: 5’- AAGCCTCTATCTGGACAGTTCTTT-3’  
 
Sept4 
Forward: 5’- ACTGACTTGTACCGGGATCG-3’ 
Reverse: 5’- TCTCCACGGTTTGCATGAT-3’  
 
Sept7 
Forward: 5’- AGAGGAAGGCAGTATCCTTGG-3’ 
Reverse: 5’- TTTCAAGTCCTGCATATGTGTTC-3’  
 
Sept8 
Forward: 5’- CTGAGCCCCGGAGCCTGT-3’ 
Reverse: 5’- CAATCCCAGTTTCGCCCACA-3’ 
 
Sept9 
Forward: 5’- GACTCCATCCTGGAGCAGAT-3’ 
Reverse: 5’- TTTGGACTTGAAGAGGGTATTGA-3’  
 
3.1.10. Mouse lines 
Plp1-/Y mice (Klugmann et al., 1997) 
Cnp1-/-, Cnp1Cre/wt mice (Lappe-Siefke et al., 2003) 
Sept4-/- mice (Kissel et al., 2005) 
Sept8fl/fl, Sept8-/- mice (Eucomm ES cells, Patzig et al., unpublished) 
Mice expressing Flp recombinase body-wide (Farley et al., 2000) 








All animals used in experiments of this thesis were bred and kept in the mouse facility of 
the Max-Planck-Institute (MPI) for Experimental Medicine. All experiments were 
performed in accordance with the guidelines for German animal welfare. All mice were 
sacrificed by cervical dislocation or by perfusion using anesthetics.  
3.2.1.1. Generation of SEPT8 deficient mice 
To generate SEPT8 deficient mice, ES cells were obtained from the European Conditional 
Mouse Mutagenesis Program (EUCOMM). ES cells were grown in the department of 
Neurogenetics of the MPI for Experimental Medicine in Göttingen by Ulrike Bode. ES cells 
were injected into FVB blastula and implanted in NMRI foster mothers. Positive 
Chimaeras were bred to wild type C57BL/6N mice gaining F1 offspring. Sept8-LacZ 
animals, containing the whole cassette described in detail (Fig. 8B and 
http://www.knockoutmouse.org/martsearch/project/33205), were recognized by 
genotyping PCR and further bred to the Flp recombinase positive mouse line to remove 
the LacZ/neo cassette resulting in floxed mice for conditional gene targeting. Homozygous 
Sept8 floxed mice (Sept8fl/fl) together with heterozygous Cnp1 mice (Cnp1cre/wt) (Lappe-
Siefke et al., 2003) were used to delete SEPT8 in oligodendrocytes and Schwann cells 
specifically. Sept8-/- mice were obtained by breeding Sept8fl/fl mice to EIIA-Cre mice to 
recombine the gene within the germ line. In all experiments Sept8fl/fl mice and Sept8wt/wt 
mice were used as controls and labeled as WT. Sept8fl/fl*Cnp1cre/wt mice were conditional 
mutants for Sept8 in oligondendrocytes and were labeled as COND. Sept8-/-, which did 
not express any SEPT8 isoform in any cell type, were constitutive mutants and were 
labeled as KO. 
3.2.1.2. Genotyping of mice 
0.5 cm long tail tips were taken from P21 young mice. They were digested overnight (o/n) 
in 180 µl 1xMGB with 20 µl Proteinase K at 55°C with agitation. To inactivate Proteinase 
K, tails were incubated for 10 min at 95°C. Polymerase chain reaction was used to amplify 
specific DNA segments (Mullis et al., 1986, Saiki et al., 1988). 1 µl of DNA samples were 
used per 20 µl PCR reaction. Primers were selected manually using the DNASTAR 





PCR reaction Sept8 gene containing lacZ/neo (wild type 448bp, Sept8-LacZ 226bp): 
4.2 µl  Go-Taq buffer (5x)   
2.1 µl   dNTP (2mM)  
0.5 µl  Primer 16459 (10 µM) 
0.5 µl   Primer 16460 (10 µM) 
0.25 µl Primer 15048 (10 µM) 
0.08 µl  GoTaq DNA polymerase  
ddH2O added to total of 20 µl. 
 
PCR reaction to detect Flp recombinase: 
4.2 µl  Go-Taq buffer (5x)   
2.1 µl   dNTP (2 mM)  
0.2 μl  Primer 15300 (10 µM) 
0.2 μl  Primer 15301 (10 µM) 
0.08 µl  GoTaq DNA polymerase 
ddH2O added to a total of 20 µl. 
 
PCR reaction Sept8 gene after FRT recombination (floxed ~569bp, null ~256bp): 
4.2 µl  Go-Taq buffer (5x)   
2.1 µl   dNTP (2 mM)  
0.1 µl  Primer 16458 (10 µM) 
0.6 µl   Primer 16459 (10 µM) 
0.6 µl   Primer 16460 (10 µM) 
0.08 µl  GoTaq DNA polymerase 
ddH2O added to a total of 20 µl. 
 
PCR reaction to detect Cre recombinase: 
4.2 µl  Go-Taq buffer(5x)   
2.1 µl   dNTP (2 mM)  
0.2 µl  Primer 4391 (10 µM) 
0.2 µl   Primer 4392 (10 µM) 
1 µl   Primer 2016 (10 µM) 
1 µl   Primer 7315 (10 µM) 
0.08 µl  GoTaq DNA polymerase 






For separation of the PCR products gels containing 2% [w/v] agarose in TAE buffer were 
used. For DNA visualization 1 µg/ml ethidiumbromide was added to the gel prior to 
polymerization. 20 µl of PCR samples were loaded and separated at 150V for 45 min in 
TAE buffer. GeneRuler 100 bp DNA ladder (Thermo Scientific, St. Leon-Rot, Germany) 
was used as a marker. For documentation pictures were obtained with the Intas UV 
system. 
 
3.2.2. Protein biochemical analysis 
3.2.2.1. Sample preparation 
Collected tissue was quickly frozen on dry ice and stored at -80°C. Sciatic nerves were cut 
on dry ice and homogenized in RIPA buffer using the Precellys (Peqlab, Erlangen, 
Germany) (6500rpm, 3x 10 sec). Lysate was incubated at 4°C for 15 min and then 
centrifuged for        10 min at 13000 rpm at 4°C. Supernatant was transferred into a new 
tube and stored at -80°C. Protein concentration was measured and samples were used 
for SDS Page. Mouse brains were used for myelin purification. 
 
3.2.2.2. Myelin purification method 
The protocol is based on the Norton and Poduslo method (Norton and Poduslo, 1973, 
Larocca and Norton, 2007). All supplies were precooled and procedure was performed on 
ice or at 4°C. Half brains were homogenized with the KINEMATICA AG POLYTRON PT 
3000 in 0.32 M sucrose containing protease inhibitor (Roche Diagnostics GmbH, 
Mannheim, Germany). 200 µl of brain lysates were stored at -80°C. For density gradient 
centrifugation, homogenate was overlaid on 0.85M sucrose and centrifuged for 30 min at 
70000xg in a swing out rotor (SW40Ti Beckman rotor, 24.400rpm) in the Beckman XL-70 
ultracentrifuge. Using the Ultra-Clear Tubes (Beckman No. 344060) the interphase could 
be nicely seen and transferred into a new tube. Water was added to the collected material 
and centrifuged again at 70000xg for 15 min. The Pellet was resuspended in water, 
incubated for 15 min and centrifuged at 12000xg for 15 min (SW40Ti Beckman rotor, 
9700rpm). This so called osmotic shock was repeated a second time. Afterwards the 
pellet was resuspended in 0.32 M sucrose and layered on 0.85 M sucrose for a second 
sucrose gradient and centrifuged at 70000xg for 30 min. The interphase was collected into 
a clean tube, water was added and it was centrifuged at 70000xg for 15 min. The pellet 
containing a myelin enriched fraction was resuspended in 200 µl 1xTBS including 







3.2.2.3. Protein concentration measurement by the Lowry method 
The Protein concentration was measured using the Bio-Rad DC Protein Assay kit 
according to the manufacturer’s 'microplate assay' protocol. The working principle of the 
kit is similar to the well-documented Lowry assay (Lowry et al., 1951, Peterson, 1979). 
The optical density was measured at 650 nm in the microplate reader ThermoMax 
(Molecular Devices, Biberach, Germany). 
 
3.2.2.4. Quantitative Mass Spectrometry  
Samples containing 100 µg of myelin in 1xTBS (3x control and 3x mutants from PLP-, 
CNP- and SEPT8-deficient mice) were sent to Dr. Stefan Tenzer, Institute for Immunology 
University Mainz. He analyzed these probes using LC-MSE, described in detail (Patzig et 
al., 2011). Experiments were performed using three biological each in four technical 
replicates. Final quantifications and diagrams were prepared with Microsoft Excel 2010 
and GraphPad Prism 5. 
 
3.2.2.5. Separating Proteins using SDS Page 
10% [w/v] or 12% [w/v] acrylamid gels were prepared using the Bio-rad system. For this, 
SDS separating gel mix was casted between a 1.5 mM thick spacer plate and thin 
coverplates. It was overlaid with isopropanol and polymerized for at least 30 min. The 
stacking gel mix was added on top after removing the isopropanol by washing with ddH2O. 
A Teflon comb (10 or 15 wells) was used to generate pockets for the protein sample. After 
polymerization gels were used immediately or were store wet at 4°C, not longer than a 
week. Proteins were separated using the protocol established by Laemmli (Laemmli, 
1970). To denature the proteins, lysates were mixed with 1x SDS sample buffer and 5% 
[v/v] mecaptoethanol, and heated for 20 min at 40°C. Bio-rad chambers were used to 
assemble the gels and filled with 1x Laemmli running buffer. Wells were washed with the 
running buffer and the protein samples were carefully pipetted in. Proteins were separated 
by constant current using the Bio-rad power supply (30 mA per gel), proteins below 40 
kDa on a 12% [w/v] gel, proteins above on a 10% [w/v] gel. After about one and a half 
hour, gels were removed, incubated for 15 min in transfer buffer and proteins were 
transferred to a PVDF membrane (immunoblot). 
 
3.2.2.6. Immunoblot 
For immunodetection, proteins were transferred to a PVDF membrane as described by 
Towbin and colleagues (Towbin et al., 1979). Therefore, the semi-dry chamber from 
Invitrogen (Karlsruhe, Germany) was used. The PVDF membrane was activated using 





buffer. Three Whatman papers soaked in transfer buffer were put onto the anode plate. 
On top, the activated PVDF membrane was layered, followed by the gel and three more 
Whatman papers. Proteins were transferred at 20 V for 40 min. 
 
3.2.2.7. Immunodetection of blotted proteins 
After the protein transfer, the PVDF membrane was blocked at room temperature (RT) for 
1 hour in blocking buffer (5% [w/v] non-fat dry milk in TBST). Primary antibody was diluted 
in the blocking buffer and incubated on the membrane o/n at 4°C. Afterwards, the 
membrane was washed three times in TBST and incubated with the HRP coupled 
secondary antibody, which was diluted in the blocking buffer, at RT for one hour. After 
additional washing with TBST, the Enhanced Chemiluminescence Detection (ECL) 
solution was added according to the manufacturer’s recommendations (Western 
Lightning™, Western Blot Chemiluminescence Reagent Plus, PerkinElmer Life Sciences, 
Inc., Rodgau, Germany). Covered from day light, a photographic film was put onto the 
membrane and then developed in a KODAK X-OMAT developer. Exposure time varied 
between 10 sec and 15 min. To re-probe the membranes with a second primary antibody, 
the membrane was incubated at 60°C for one hour with the immunoblot stripping buffer 
followed by additional washing with TBST and blocking. Films were scanned in with 300 
dpi using the Epson F-3200 scanner. Scanned pictures were cut using Adobe Photoshop 
CS3 and arranged in Adobe Illustrator. Signal intensities were measured using the gel 
analysis of Fiji (http://fiji.sc/). The normalized values (±SEM) were shown as histograms 
using Microsoft Excel 2010 and p-values were calculated using the Student’s t-test of 
Microsoft Excel 2010. 
 
3.2.3. RNA isolation and analysis 
3.2.3.1. RNA isolation (‘RNeasy mini prep’) 
Small scale RNA isolation from separated corpus callosum of male mice was performed 
using “Qiagen’s RNeasy Mini Prep” kit. The kit is based on a selective binding of RNAs 
bigger than 200 bases to a silica-gel based membrane under high-salt conditions, which 
excludes binding of 5S, 5.8S and tRNAs. RNA isolation and purification was carried out 
following the manufacturer’s instructions. Briefly, the frozen tissue (-80ºC) was 
homogenized in Trizol (Invitrogen, Karlsruhe, Germany) with the Ultra-Turrax T8 for 30 
sec. 200 µl chloroform was added to 0.6ml homogenate, vortexed and incubated for 3 
min. After 15 min certification at 16000xg (Heraeus Biofuge Pico table centrifuge, 
13000rpm) the upper aqueous phase was transferred to a new 2 ml Eppendorf tube. One 
volume of ethanol was added to the samples, mixed and applied to RNeasy columns. 





buffer and two times with the RPE buffer. RNA was eluted with 50 µl of RNase-free 
ddH2O. 
 
3.2.3.2. RNA measurement with Agilent 
The quality and the amount of RNA were measured using the Agilent RNA 6000 Nano KIT 
and the Agilent 2100 Bioanalyzer following the company’s instructions. Only RNA samples 
with a RNA integrity number above 8.5 were further used. The RNA concentration for all 
samples was adjusted to 100 ng/µl. 
 
3.2.3.2. cDNA synthesis 
In order to analyze the specific RNA expression profiles, the RNA repertoire isolated from 
mouse tissue was converted to a complementary single stranded DNA (cDNA) library. 
First-strand cDNA was synthesized in a reverse transcription reaction catalyzed by RNA 
dependent DNA polymerase SuperScript III (Invitrogen, Karlsruhe, Germany) at 55ºC.  
 
cDNA synthesis protocol: 
8 μl  RNA (800 ng total) 
2 µl  dT mix Primer (0.6 pmol/µl) 
2 μl  N9 (random nonamers 120 pmol/μl)  
To denaturate RNA and primers, the mixture was incubated for 10 min at 70ºC and 1 min 
on ice. 
 
Afterwards the following premix was added to the reaction: 
4 μl  5x first strand buffer 
1 μl  dNTP (10 mM) 
2 μl  DDT (100 mM) 
1 μl  SuperScript III reverse transcriptase (200 U/μl) 
 
The final 20μl reaction mixture was incubated in a thermocycler with the following settings: 
25ºC  10 min 
50ºC  45 min 
55ºC  45 min 






3.2.3.3. Quantitative real time PCR (qRT-PCR) 
qRT-PCR was performed using SYBR Green Master Mix according to the manufacturer’s 
instructions (Applied Biosystems, Darmstadt, Germany). The mixture for the gene 
expression analysis contained 5 μl of SYBR Green Master Mix, 4.8 µl of cDNA (1.6 ng/µl) 
and 0.1 µl of each primer (10 pmol/µl). Primers were selected with the Universal Probe 
Library form Roche Applied systems (https://www.roche-applied-science.com). Reactions 
were performed in quadruplicates. PCR reaction was carried out using following 
temperature conditions; 60°C for 1 min, 95°C for 15 sec [45 cycles]. Analysis of the 
measurements was done with the Applied Biosystems 7500 Fast Real-Time PCR System. 
Results were displayed as histograms of relative RNA abundance with respect to 
cyclophilinA (Ppia). Diagrams and quantifications were prepared with GraphPad Prism 5. 
The Student’s t-test was used for p-value quantification. 
 
3.2.4. Histological analysis 
3.2.4.1. Teased fiber preparation 
Sciatic nerves were dissected and kept in ice cooled 1xPBS. Fine forceps (Dumont #5 
forceps, fine scientific tools) were used to remove the epineurium and to separate single 
axons on a glass slide. Teased fibers were dried at RT and stored at -20°C.  
 
For immunohistochemistry, samples were incubated for 5 min with 4% [w/v] PFA and 5 
min with chilled Methanol (-20°C). After washing three times with 1xPBS, blocking buffer 
was applied for 45 min. Primary antibodies were diluted in blocking buffer and incubated 
o/n at 4°C. The next day, excess antibody was washed off followed by incubation with the 
fluorophore-coupled secondary antibodies for two hours at RT. The samples were washed 
three times with 1xPBS, incubated with DAPI (1:10000) for 5 min and washed again. 
Tissue was mounted using Aqua-Poly/Mount (Polysciences, Eppelheim, Germany).  
  
3.2.4.2. Perfusion fixation of mouse tissue 
Mice were anesthetized by injection of avertin intraperitoneally (0.2 ml per 10 g of body 
weight). After confirming successful anesthesia by pinching the hind paw, animals were 
stabilized with the ventral side up. The abdomen was opened and the diaphragm was 
removed to expose the heart. A butterfly cannula (27G, Venofix) connected to a peristaltic 
pump was injected into the left ventricle, while the right atrium was cut, generating a small 
opening. The blood was flashed out for 4 min with warm (37°C) HBSS (Invitrogen, 
Karlsruhe, Germany). Afterwards 40-50 ml warm fixative was used to fix the tissue. 
Depending on the further use different fixatives were used. All used mice were again 






3.2.4.3. Immunohistochemistry of cryosections 
Mice were perfused using 4% [w/v] PFA. After fixation, tissue was transferred to 10% [w/v] 
sucrose in 0.1M phosphate buffer. After one hour at 4°C, tissue was first transferred to 
20% [w/v] sucrose and then to 30% [w/v] sucrose in 0.1 M phosphate buffer, each o/n at 
4°C. Following this cryo-protective step, brain and spinal cord were frozen and stored at -
20°C. A cryostat (Leica, Wetzlar, Germany) was used to generate 20 µm thick longitudinal 
or transverse sections of stabilized tissue, which were collected on glass slide and dried at 
RT and stored at -20°C. For immunofluorescent stainings, tissue was incubated with the 
blocking buffer for 1 hour. The primary antibodies were diluted in the blocking buffer and 
incubated at 4°C for 40 hours. Afterwards, slides were washed three times for 10 min with 
1xPBS and incubated for two hours with the secondary antibodies at RT. After additional 
washing with 1xPBS, tissue was incubated with DAPI (1:10000) for 5 min and was 
washed again. Tissue was mounted using Aqua-Poly/Mount.  
  
3.2.4.4. Imaging of fluorescent stainings 
Slides were imaged with the confocal microscope Leica SP5. Signal was collected 
sequentially with the objective HCX PL APO lambda blue 63.0x1.20 WATER UV. An 
argon laser with the excitation of 488 nm was used to excite the Alexa488 fluorophore and 
the emission was set to 500 nm - 560 nm. Cy3 was excited with the DPSS561 at an 
excitation of 561 nm and the emission was set to 573 nm – 630 nm. The HeNe laser was 
used to excite Dyelight633 with 633 nm and emission was detected between 645 nm – 
738 nm. DAPI was excited with 405 nm and collected between 417 nm – 480 nm. The 
LAS AF lite and Fiji were used to export the images as tif-files.  
 
3.2.4.5. Detection of β-galactosidase in tissue sections (X-gal staining)  
The bacterial enzyme β-galactosidase catalyzes the cleavage of the O1 bond of the sugar 
β-D-galactose to a substituent. The enzyme is specific to cleave organic compounds such 
as 5-bromo4-chloro-3-indolyl-β-D-galactoside (X-gal) generating blue precipitate (5-
bromo-4-chloro-3- hydroxyindole) under oxidizing buffer conditions. Cloning this enzyme 
in front of regulatory element of genes and monitoring its activity in vivo, enables gene 
transcription analysis (Goring et al., 1987, Sanes, 1994). To detect β-galactosidase 
activity in Sept8_LacZ mice, 100 μm vibratome sections were prepared from mouse 
brains previously perfused with 4% [w/v] PFA. Sections were placed in β-gal staining 
buffer for 1-2 hours at 37°C in the dark. To stop the X-gal reaction, sections were washed 





slipped with Aqua-Poly/Mount. Tissue sections were imaged using the Zeiss Axio Z1 with 
the Zen 2011 software (Zeiss, Oberkochern, Germany). 
 
3.2.4.6. Tissue processing using paraffin 
Mice were perfused with 4% [w/v] PFA and post-fixed o/n at 4°C. For thin sectioning, 
brains were embedded in paraffin (Paraplast, Leica, Wetzlar, Germany) using an 
automated system (HMP 110, MICROM) with the following program: 
 
Procedure Time 
50% [v/v] Ethanol  1 hour 
70% [v/v] Ethanol  2x 2 hours 
96% [v/v] Ethanol  2x 2 hours 
100% [v/v] Ethanol  2x 2 hours 
Isopropanol 1 hour 
Xylol 2x 2 hours 
Paraffin 2x 2 hours 
 
Afterwards, the tissue was placed in metal forms and casted in blocks with 60°C warm 
paraffin. Labeled paraffin blocks were cooled and stored at RT. The tissue was cut in       
5 µM thick sections using the microtome (HM 400, MICROM) and dried at RT. 
 
For further use, sections were deparaffinized by the following steps: 
Procedure Time 
60°C 10 min  
Xylol 2x 10 min 
Xylol/Isopropanol (1:1) 10 min 
100% [v/v] Ethanol 5 min 
90% [v/v] Ethanol 5 min 
70% [v/v] Ethanol 5 min 
50% [v/v] Ethanol 5 min 
ddH2O 5 min 
 
3.2.4.7. Gallyas silver impregnation 
Deparaffinized 5 µM brain sections were used to visualize myelin. The technique 
developed by Gallyas based on binding of colloidal silver particles to myelinated fibers 
(Gallyas, 1979). First, sections were incubated with a 2:1 mixture of pyridine and acetic 





washed with ddH20 three times 10 min each, incubated in warm incubation solution for 10 
min and washed with 0.5% [v/v] acetic acid three times for 5 min. Afterwards, sections 
were incubated in the developer solution for 4 min and the reaction was stopped by 
washing in 1.0% [v/v] acetic acid. After additional washing with ddH2O, silver staining was 
stabilized by incubation with 2% [v/v]  sodium thiosulfate solution for 5 min. Tissue was 
dehydrated by an alcohol gradient (50% [v/v], 70% [v/v], 90% [v/v], and 100% [v/v] for 5 
min each), incubated with Xylol/Isopropanol (1:1, 5 min) followed by two times Xylol (5 
min) and mounted using Eukitt. 
 
3.2.4.8. Immunohistochemistry of paraffin embedded tissue 
5 µM thin brain sections were used to label neuropathological markers. Deparaffinized 
tissue was incubated in citrate buffer for 5 min and then cooked for 10 min in boiling 
citrate buffer to permeabilize the tissue (650 watts in microwave oven). After cooling for 
about 20 min, sections were rinsed with Tris buffer containing 2% [w/v] milk powder. Glass 
slides were placed into Shandon coverplates (Thermo Scientific, Cheshire, UK) for even 
distribution of solutions and rinsed again with Tris buffer containing 2% milk powder. For 
paraffin embedded brain sections horse radish peroxidase (HRP) coupled secondary 
antibodies were used. Therefore, it was necessary to inhibit the endogenous peroxidase 
activity by applying 3% [v/v] hydrogen peroxide for 5 min. After additional washing with 
Tris buffer containing 2% [w/v] milk powder, slides were incubated in the blocking solution 
(20% [v/v] goat serum in BSA/PBS) for 30 min at RT. Primary antibodies were diluted in 
BSA/PBS and incubated o/n at 4°C. Subsequently, slides were washed with Tris buffer 
containing 2% [w/v] milk powder. For visualization of amyloid beta precursor protein (APP) 
the LSAB2 kit (Dako, Hamburg, Germany) was used. The sections were incubated with 
100 μl of bridging antibody i.e. a biotinylated secondary antibody for 10 min at RT and 
rinsed with Tris buffer containing 2% [w/v] milk powder. The HRP complex bound antibody 
was incubated for 10 min at RT. For detection of MAC-3, slides were incubated with the α-
rat-biotinylated antibody for 30 min. Then, the Vector Elite ABC Kit (Vector Labs, 
Loerrach, Germany) was incubated for 30min. The coverplates were removed and all 
sections were rinsed with Tris buffer without milk-powder. The HRP substrate 3,3'-
Diaminobenzidine (DAB) was applied by using the DAB Zytomed Kit (Zytomed Systems 
GmbH, Berlin, Germany) and incubated for 10 min. Brown labeling appeared where 
antibodies recognized their targets. After additional washing with ddH2O, sections were 
incubated in 0.1% [w/v] Haematoxylin for 5 min to label nuclei. Blue coloration appears 
due to the interaction with the basic nuclear compartment. Sections were rinsed with 
ddH2O, incubated with HCl-Alcohol for 5-10 sec and with Scott’s solution for 5 min. This 





3-5 min and another rinse with ddH2O. Tissue was dehydrated by an alcohol gradient 
(50% [w/v], 70% [w/v], 90% [w/v], and 100% [w/v] for 5 min each), incubated with 
Xylol/Isopropanol (1:1, 5 min) followed by two times Xylol (5 min) and mounted using 
Eukitt. 
 
3.2.4.9. Imaging and quantification of DAB developed stainings 
Tissue was imaged using the Zeiss Axio Z1 with the Zen 2011 software (Zeiss, 
Oberkochern, Germany). The quantification of MAC-3 signal was done with Fiji. First, the 
color threshold was used to transform the colored picture to a black and white one; brown 
signal represented by positive black signal. Second, the area of the positive black signal 
was measured and related to the size of the analyzed area. Diagrams, quantification and 
Student’s t-test (p-value) were prepared with Microsoft Excel 2010. 
 
3.2.5. Electron microscopy 
3.2.5.1. Tissue preparation 
Optic or sciatic nerves were fixed with Karlsson-Schultz fixative to analyze myelin 
structure at ultrastructural level. For immunoelectron microscopy (IEM), optic nerves were 
fixed only for one hour in immuno-Karlsson-Schultz fixative and then stored in 1% [w/v] 
PFA. 
 
3.2.5.2. Epon embedding 
Karlsson-Schultz fixed optic or sciatic nerves for subsequent EM imaging were embedded 
using an automated system (EMTP, Leica, Wetzlar, Germany). Steps included 
osmification, dehydration and Epon impregnation. Prior to embedding, tissue was washed 
from the fixative with 0.1 M phosphate buffer and placed into the plastic chambers. 
Chambers were then placed into the machine for embedding and tissue was processed 






Solution Incubation time  Temperature 
Phosphate buffer 3 times 10 min 4ºC 
2% [w/v] OsO4  4 hours  4ºC 
ddH2O 3 times 10 min  4ºC 
30% [v/v] Ethanol  20 min  4ºC 
50% [v/v] Ethanol  20 min  4ºC 
70% [v/v] Ethanol  20 min  4ºC 
90% [v/v] Ethanol  20 min  4ºC 
100% [v/v] Ethanol  4 times 10 min  4ºC 
Propylenoxid  3 times10 min  RT 
Propylenoxid/Epon 2:1  2 hours  RT 
Propylenoxid/Epon 1:1  2 hours  RT 
Propylenoxid/Epon 1:2  4 hours  RT 
Epon  4 hours RT 
Tissue was then placed into the labeled Epon filled molds and left o/n at 60ºC for Epon 
polymerization. 
 
3.2.5.3. Sectioning of Epon embedded optic or sciatic nerves 
Epon embedded nerves were cut using the microtome (Ultracut S, Leica, Wetzlar, 
Germany). A diamond knife (Diatome Ultra 45º) was used to prepare semi-thin (300 nm) 
and ultra-thin (50 nm) sections. Semi-thin sections were collected onto a glass slide and 
dried on a 60°C hot plate. 50 nm sections were placed on a double sized slot grid (2mm-
1mm, AGAR scientific, Essex, UK) coated with formvar polyvinyl and contrasted. 
 
3.2.5.4. Staining of semi-thin sections 
300 nm thin sections of optic or sciatic nerves were labeled using the Methylene blue-     
Azure II stain (Richardson et al., 1960). On a 60°C hot plate, sections were incubated for 
1 min and then extensively rinsed with ddH2O. After drying, tissue was mounted using 
Eukitt and imaged with the Zeiss Axio Z1 (Zeiss, Oberkochern, Germany). 
 
3.2.5.5. Contrasting of ultra-thin sections 
Grids were placed upside-down on drops of the following solutions: 
30 min  Uranyl acetate (covered from daylight)  
3x 1 min  ddH2O 
6 min  Reynolds lead citrate 
4x 1 min  ddH2O 





3.2.5.6. Analysis of EM pictures 
Ultra-thin sections were analyzed with the Zeiss EM900 (Zeiss, Oberkochen, Germany) 
and digital pictures were obtained using the wide-angle dual speed 2K-CCD-Camera 
(TRS, Moorenweis, Germany). G-ratio measurements and quantifications of myelin 
abnormalities were performed using Fiji. Microsoft Excel 2010 was used for diagrams and 
statistical tests (p-value, Student’s t-test). Presentation of pictures was prepared using 
Adobe Photoshop CS3 and Microsoft PowerPoint 2010.  
 
3.2.5.7. Immunoelectron microscopy 
Immunoelectron microscopy was performed by Dr. Wiebke Möbius and Ramona Jung. 
Fixed optic nerves were immersed with 2.3 M sucrose in 0.1 M phosphate buffer o/n, 
mounted onto aluminium pins for ultramicrotomy and frozen in liquid nitrogen. 50 nm thin 
cryosections were cut with the EM UC6i ultramicrotom (Leica, Wetzlar, Germany) and 
were picked up in a 1:1 mixture of 2% [w/v] methylcellulose and 2.3 M sucrose (Liou et al., 
1996). Sections were blocked with 1% [w/v] BSA in PBS. Primary antibodies were diluted 
in 0.1% [w/v] BSA/PBS and prepared according to (Roth et al., 1978, Slot and Geuze, 
1985), incubated with the sections for 30 min and detected with protein A-gold (10 nm). 
For double labeling, antibody incubation occurred sequentially: first the antibody directed 
against SEPT9 using protein A-gold 10 nm and second, the antibody directed against 
SEPT8 visualized by protein A-gold   15 nm. Detailed information for the IEM methods 
was published previously (Werner et al., 2007). Sections were analyzed with a LEO 
EM912 Omega (Zeiss, Oberkochen, Germany) and digital micrographs were obtained 
with an on-axis 2048x2048-CCD camera (TRS, Moorenweis, Germany). Presentation of 
pictures was prepared using Adobe Photoshop CS3 and Microsoft PowerPoint 2010.  
 
3.2.6. Induction of experimental autoimmune encephalomyelitis in mice 
Experimental autoimmune encephalomyelitis (EAE) was induced in 15-week old female 
mice. They were immunized by sub-cutaneous injection with 200 µl (bilateral injection in 
the inguinal and the scapular area; 50 µl in each injection site) of MOG 35-55 (1.25 mg/ml) 
(total MOG/mouse; +/- 250 µg) emulsified in complete Freund adjuvant (CFA) (Rao and 
Segal, 2012). This injection was performed by the trained colleague Benoit Barrette, Ph.D. 
Right after the immunization and 48 hours later, 500 ng of Pertussis toxin was injected 
intraperitoneally (diluted in a total volume of 300 µl). Mice were observed daily. Thereby, 






EAE score Symptoms 
0.5 loss of tail tip tone 
1 loss of tail tone 
1.5 ataxia, mild walking deficits (slipping off the grid) 
2 
mild hind limb weakness, less frequent walking and with obvious 
deficits, can’t stay hanging on a flipped grid, twisting of the tail 
causes rotation of the whole body 
2.5 
moderate hind limb weakness, not walking by itself, but capable 
after nudging, can’t grip the grid with hind paw, but able to stay on 
a 90°(upright) tilted grid (water and food was added in the cage) 
3 
complete hind limb weakness, falls down from a 90°(upright) tilted 
grid 
3.5 hindlimb plegic 




For immunohistochemistry, animals were perfused with 4% [w/v] PFA, tissue was 
embedded in paraffin (section 3.2.4.6) and processed as described in section 3.2.4.8/9. . 






4.1. The septin cytoskeleton of central nervous system myelin 
4.1.1. Mass spectrometric and immunoblot characterization of mature CNS 
myelin 
To approach the molecular basis for the biogenesis, structure and function of myelin, its 
protein content has recently been reinvestigated using current biochemical methods. 
Already in the year 1973 a protocol was established to isolate myelin from other cellular 
structures (Norton and Poduslo, 1973, Larocca and Norton, 2007). The method has been 
moderately adapted and combined with modern mass spectrometry (MS). Thereby, it was 
possible to newly identify many proteins in CNS myelin, and to determine their relative 
abundance quantitatively (Jahn et al., 2009, de Monasterio-Schrader et al., 2012, Jahn et 
al., 2013). 
To control for myelin enrichment, brain lysates and purified myelin were compared by 
immunoblot (Fig. 4A). As expected PLP and CNP, two myelin markers exclusively 
expressed by oligodendrocytes in the brain, were strongly enriched in the myelin fraction. 
In contrast, axonal markers such as neurofilament light chain and beta-3-tubulin were 
diminished. Notably, axonal marker proteins were not entirely absent from the myelin 
fraction, reflecting that biochemical fractions are never pure. In the applied quantitative 
MS of myelin performed by Dr. Stefan Tenzer, Institute for Immunology University Mainz, 
abundant axonal proteins might thus be detected as low-abundant contaminants. 
Several members of the septin protein family were found by MS as abundant in the myelin 
fraction and were further analyzed by immunoblot. Three of them, namely SEPT2, SEPT4 
and one isoform of SEPT8 were enriched in the myelin fraction (Fig. 4B). SEPT7 and 
SEPT9 were detected at about equal intensity in lysate and myelin. SEPT11 was 
diminished in myelin compared to brain lysate, but nevertheless detectable.  
For quantitative MS, myelin was purified from C57BL/6N mouse brains (n=9). In three 
individual experiments SEPT2, SEPT4, SEPT7 and SEPT8 were detected as abundant 
proteins. For comparison, MAG was five times more abundant than SEPT8. SEPT9 was 
detected, but below the set threshold. SEPT11 was detected as very abundant in one 
experiment out of three. As seen in Fig. 4B, SEPT11 was very abundant in brain lysate 
and strongly reduced in myelin suggesting that SEPT11 might have been detected as 
false positive.  
Fig. 4C shows a quantitative evaluation of the septins reliably detected in myelin. SEPT8 





abundance of SEPT7 was determined to be about 80% compared to SEPT8. SEPT2 and 
SEPT4 were about 40% and 50% as abundant as SEPT8 respectively.  
Myelin from PLP and CNP mutant mice was purified and compared to controls by 
quantitative MS. The abundance of SEPT8 was found to be reduced to about 50% in both 
mutants, whereas that of SEPT2 was reduced to 50% in PLPnull and to 70% in CNPnull 
myelin. In contrast, the abundance of SEPT4 and SEPT7 was reduced to 30% and 50% in 
CNPnull myelin respectively, while in PLPnull myelin the abundance of SEPT4 was reduced 
to only 75% and SEPT7 to 50%. Taken together, PLPnull and CNPnull mutant myelin display 
a principally reduced abundance of septins in CNS myelin. Both of these mutants display 
myelin abnormalities and axonal pathology (Griffiths et al., 1998, Lappe-Siefke et al., 
2003). Here, we asked if the altered septin abundance is a relevant pathological aspect of 





Fig. 4. Biochemical characterization of CNS myelin. A Myelin purified from mouse brains was 
compared to brain lysates by immunoblot analysis. Myelin proteins as CNP and PLP were enriched 
in the myelin fraction whereas axonal proteins as neurofilament and beta-3-tubulin were 
diminished. B Several members of the septin protein family were identified as abundant in myelin. 
SEPT2, SEPT4 and one isoform of SEPT8 were enriched, whereas SEPT7, SEPT9 and SEPT11 
were of about equal abundance or diminished in the myelin fraction. C Quantitative MS was used 
to determine the relative abundance of septins in the myelin fraction. SEPT2, SEPT4, SEPT7 and 
SEPT8 were reliably identified in three independent experiments and compared to each other (C, 
error bar: SEM). D Myelin purified from CNP
null
 (blue) and PLP
null
 (orange) mice was compared to 
control by quantitative MS. In myelin of both mutant mouse lines, the abundance of septins was 





4.1.2. Subcellular localization of septins in mature CNS myelin 
By biochemical analysis, septins were found to be very abundant constituent of CNS 
myelin. This made it interesting to determine the localization of these newly identified 
myelin proteins. Using fixed optic nerves of adult mice, immunoelectron microscopy (IEM) 
was performed to identify the exact localization of SEPT8. As shown in Fig. 5A, gold 
particles labeling SEPT8 were exclusively associated with adaxonal myelin, the 
oligodendroglial compartment closest to the axon. Gold particles were not distributed 
equally, as seen in transverse sections (Fig. 5A right). Some sectioned adaxonal myelin 
compartments did not show any labeling while others were labeled only on one side.  
To elucidate the localization of myelin septins in relation to known myelin markers, double 
immunohistochemistry was performed on cryosections of mouse spinal cord. The ventral 
spinal cord contains very large axons, allowing a good resolution by confocal microscopy. 
The myelin protein MAG is a known marker of the adaxonal myelin membrane (Trapp and 
Quarles, 1982, Trapp et al., 1989). It was labeled intensely all around the axons (Fig. 5B). 
SEPT8 was localized to MAG-positive structures, confirming its adaxonal localization. 
However, SEPT8 labeling was restricted to a punctate-appearing subdomain. Together, 
SEPT8 labeled a novel subdomain of the adaxonal myelin compartment. 
Confocal stacks were taken from fluorescent immunohistochemical stainings of 
longitudinal sections of spinal cord (Fig. 6A and B). Using Imaris Software, it was possible 
to reconstruct 3-dimensional images with planes of a voxel depth of 130 nm and a voxel 
width/height of 40 nm. In Fig. 6A every 5th plane is shown (distance of 5 times 130 nm). A 
filament-like assembly of SEPT8 was observed gently undulating around the axon (Fig. 
6A and B). The filament-like domains varied in length and reflected the distribution of 
SEPT8 in transverse planes, as observed in both the spinal cord and the optic nerve.  
To better define the longitudinal organization of the SEPT8-positive domain, co-labeling 
experiments were performed of SEPT8 with known markers of various axonal segments 
(Fig. 6C and D). The nodes of Ranvier are flanked by the paranodal loops of non-compact 
myelin. This segment was labeled with antibodies specific for Caspr, an axonal protein 
connected to the paranodal loops (Einheber et al., 1997). SEPT8 was never found in 
close relation to Caspr (Fig. 6C). Additionally, SEPT8 was co-labeled with Kv1.2, thus 
labeling the potassium channels in the juxtaparanodal segment (Wang et al., 1993). 
SEPT8-labeling was found in close proximity to Kv1.2-labeling, thus identifying the 







Fig. 5. Septins localize to adaxonal CNS myelin. A SEPT8 was visualized by immunoelectron 
microscopy in optic nerves of wild type mice. In myelin, gold particles were restricted to the 
adaxonal subcompartment. In transverse sections, it was apparent that SEPT8 was not equally 
distributed but often confined to one side of the axon. Labeling and pictures were prepared by Dr. 
Wiebke Möbius (Neurogenetics, MPI Exp.Med. Göttingen). B SEPT8 (green) and MAG (red) were 
labeled in the ventral white matter of the spinal cord. Antibodies specific for MAG labeled the entire 
adaxonal myelin compartemnt, while SEPT8 was restricted to one to three punctae, which clearly 






Fig. 6. Septins localize to an internodal, adaxonal myelin subcompartment. A and B A 
confocal stack was taken and every 5
th
 sectional plane is shown (A). SEPT8 (green) formed an 
about 10 µM long rod gently undulating along the axon (red). This confocal stack was transformed 
in a 3-dimensional reconstruction with the Imaris software (B). C and D The localization of SEPT8 
was analyzed in relation to the node of Ranvier (*). When the paranodal segments were marked 
using antibodies specific for Caspr (C, red), no co-labeling with SEPT8 was found. In contrast, 
SEPT8 was detected in the juxtaparanodal segment marked by potassium channels (D, red). 
SEPT8-labeling is in agreement with filament-like domains in the adaxonal internodal myelin 








To test if myelin septins display similar localizations, immunohistochemistry was applied to 
spinal cords and optic nerves. Exemplified with SEPT9, other myelin septins displayed the 
same punctate labeling as SEPT8 (Fig. 7A). Indeed, SEPT9 co-labeled with SEPT8 
according to IEM (Fig. 7B), in which both septins were co-distributed in close proximity in 
the adaxonal internodal myelin. 
Taken together, a novel domain was identified in the adaxonal internodal myelin 
compartment that was specifically defined by the localization of a distinct set of septins. 
SEPT8 was not detected in the paranodal loops, reflecting a specialization of the different 
segments of non-compact myelin. 
 
Fig. 7. The localization of SEPT9 in myelin is similar to that of SEPT8. A SEPT9 (green) was 
labeled in a transverse section of the spinal cord. Similar to SEPT8-labeling, SEPT9-labeling in 
transverse sections appeared punctate and was restricted to adaxonal myelin. Neurofilaments 
were labeled in red; no SEPT9 was detected within the axon. B By immunoelectron microscopy, 
double-visualization of SEPT8 (large black puntca, constituted by 15 nm gold particles) and SEPT9 
(small black puntca, constituted by 10 nm gold particles) was performed. Septins localized together 
in adaxonal myelin (arrow head). IEM co-labeling and pictures were prepared by Ramona Jung 









4.2. Targeted loss of septins from oligodendrocytes 
4.2.1. Generation of mice lacking SEPT8  
To test the functional requirement of myelin septins and the novel domain that they 
constitute for myelin stability and axonal integrity, mice lacking SEPT8 conditionally or 
constitutively were generated.  
Embryonic stem (ES) cells harboring an engineered Sept8-allele were acquired from the 
European Conditional Mouse Mutagenesis Program (EUCOMM) and injected into 
blastocysts to generate genetically engineered mice. The gained knock-in allele contained 
a LacZ containing cassette, which was used to analyze the cellular expression of the 
Sept8 gene. Sagittal brain sections were applied to β-galactosidase histochemistry (Fig. 
8A). Sept8 was strongly expressed in the cortex, the hippocampus and the cerebellum in 
a pattern suggesting neuronal expression. The white matter of the brain was also stained. 
Here, positive cells were found in a chain-like distribution in agreement with 
oligodendrocytic expression.  
Since the role of SEPT8 in oligodendrocytes was to be analyzed, conditional deletion of 
Sept8 was necessary to not affect its possible neuronal function. First, the lacZ/neo 
cassette was removed by in vivo recombination using the Flp recombinase. This led to 
mice, in which exon 2 of the Sept8 gene was flanked by loxP sites. Secondly, Cre 
recombinase, expressed under control of the Cnp1-promotor (Lappe-Siefke et al., 2003), 
was used to remove exon 2 of the Sept8 gene in vivo, thereby abolishing the expression 
of any SEPT8 isoform in oligodendrocytes (Fig. 8B). Primers for genotyping PCRs were 
selected to identify mice positive for the Sept8 allele harboring the loxP sites and/or to 
detect the deletion of exon 2 (Fig. 8B). The PCR amplicon of the loxp-site flanked allele 
was, as expected, about 100bp larger than that of the wild type allele (Fig. 8C). In 
conditional knock-out mice and in constitutive knock-out mice the deletion of exon 2 was 








Fig. 8. Generation of mice harboring altered alleles of the Sept8 gene. A The modified Sept8 
allele containing a LacZ cassette was used to analyze Sept8 gene activity. Gene activity was 
marked by the blue reaction product of the β-galactosidase histochemistry. The Sept8 gene was 
strongly active in the grey matter of the cortex, the hippocampus and the cerebellum. The 
enlargement shows that presumptive oligodendrocytes were labeled in the white matter as 
exemplified for the cerebellum. B By flippase-mediated recombination of FRT sites in vivo, the lacZ 
cassette was removed from the Sept8 allele (step I to II), and then exon 2 was removed by Cre 
recombinase activity at loxP sites (step II to III) C The various Sept8 alleles were identified by PCR.  
 
To determine if indeed expression of SEPT8 was disrupted in SEPT8 mutant mice, and as 
a control for the results presented in section 1.2, immunohistochemistry with antibodies 
specific for SEPT8 was performed using spinal cords of control mice (WT) and conditional 
SEPT8 mutants (Sept8fl/fl*Cnp1cre/wt, COND) at the age of P75. In control mice, SEPT8 
punctae localized to the MAG-positive compartment, reflecting its adaxonal localization. In 
the spinal cord, SEPT8 was never found together with an axonal marker (neurofilament, 
NF). Thus, SEPT8 was undetectable in axons of the spinal cord. In the conditional 
mutants of SEPT8 (COND) hardly any signal was detected. Only some faint signal could 






Fig. 9. Deletion of SEPT8-expression from oligodendrocytes. A Immunohistochemical analysis 
of the ventral white matter on transverse sections of spinal cord. Control mice (WT) showed 
punctae (arrows) of SEPT8 labeling (green) in the adaxonal myelin labeled by MAG (red). These 
domains were lateral to the axons and never co-localized with neurofilaments (NF, red). In 
conditional SEPT8-mutants (COND), lacking SEPT8 specifically from oligodendrocytes, almost no 
green signal was detectable in white matter tracts. B Immunoblots confirmed the loss of SEPT8 in 
brain lysates and myelin. Conditional SEPT8-mutants (COND) showed a clear loss of SEPT8 in the 
myelin fraction while constitutive mutants (KO) were devoid of SEPT8. The abundance of CNP was 
reduced in conditional mutants (COND) due to the Cnp1
cre/wt
 genotype inferred by the Cre driver 
line. 
To determine if the abundance of myelin septins is affected by the absence of SEPT8, 





brains at the age of P75 (Fig. 9B). Control mice (WT) were compared to conditional 
mutants (Sept8fl/fl*Cnp1cre/wt, COND) and to constitutive mutants (Sept8-/-, KO). Comparing 
the SEPT8-specific bands detected in brain lysates of WT to COND, no decrease in the 
two most abundant isoforms of SEPT8 was observed. A very faint band migrating just 
above the smaller isoform was not detected in the COND brains. In the KO brains all 
SEPT8-specific signal was absent, confirming the successful deletion of SEPT8. Myelin 
was purified and compared to brain lysates. In WT myelin, only one band was visible, 
which was absent from COND and KO mice. This band likely represents the medium-
sized isoform of SEPT8. In the myelin fraction of COND some signal was present, which 
replicated the same pattern as seen in the brain lysates. This signal in the myelin fraction 
of COND likely reflects contaminants in the myelin fraction. In myelin of KO no signal 
could be detected, confirming both, the successful gene targeting and the specificity of the 
antibodies. 
The abundance of CNP was determined in lysate and myelin comparing control (WT) and 
mutant mice (COND, KO). As expected, CNP was always enriched in the myelin fraction. 
Comparing COND to WT and KO, the abundance of CNP was reduced in lysate and 
myelin because the Cre recombinase was knocked-in the native Cnp1 gene leading to 
heterozygous expression of CNP (Lappe-Siefke et al., 2003). Myelin purification was also 
confirmed by the increased abundance of the myelin marker PLP and the diminished 
abundance of the axonal marker beta-3-tubulin (Fig. 9B). 
In summary, it was shown that the use of the EUCOMM ES cells and the following in vivo 
recombination using the Cnp1 promoter-driven expression of Cre recombinase facilitated 
the absence of SEPT8 in mice, in particular from CNS myelin. This was confirmed by 
immunohistochemistry and immunoblot. Within the white matter of the spinal cord, SEPT8 
was mainly detected in oligodendrocytes, reflected by the loss of almost all signal in 
COND mice and the absence of detectable signal in axons. In brain, other cells additional 






4.2.2. SEPT8 is essential for the presence of the septin filament in CNS myelin 
After the successful deletion of SEPT8-expression, the abundance of potentially 
interacting septins was tested by immunoblot (Fig. 10A). Several septins, which were 
previously identified to be present in myelin by MS, were strongly diminished in the myelin 
of COND and KO when compared to WT. SEPT2, SEPT4 and SEPT7 were reliably 
detected in CNS myelin of control brains, but could hardly be detected in SEPT8 mutants. 
When SEPT8 was missing from oligodendrocytes, SEPT9 (40kDA isoform) was also 
diminished. Conversely, the abundance of SEPT11 in myelin was unchanged when 
SEPT8 was deleted.  
 
To identify all molecular changes in the myelin of SEPT8 deficient mice, myelin of WT and 
KO (3 probes each) were compared using quantitative mass spectrometry (Fig. 10B). No 
increased abundance of any protein has been detected comparing WT and KO. The 
abundance of only 10 proteins was significantly reduced in SEPT8-deficient myelin, 5 of 
them to below the set threshold of 50%. As expected, SEPT8 could not be detected due 
to the genetic deletion. In accordance with the immunoblots (above), SEPT2 and SEPT4 
were almost completely lost and SEPT7 was decreased to about 20%. In addition, one 
new interesting candidate was identified, namely anillin. The abundance of anillin was also 
strongly reduced to about 10%. Thus, SEPT8 was found to be essential for the presence 
of several other septins and of anillin in CNS myelin.  
 
To understand if the reduced abundance of several septins in myelin of SEPT8 deficient 
mice is due to gene regulation or a post-transcriptinal cause, mRNA abundance was 
analyzed by qRT-PCR (Fig. 10C). To enrich for oligodendrocytes, corpus callosi of mouse 
brains were dissected and mRNA was isolated. Control mice (WT) included Sept8wt/wt and 
Sept8fl/fl*Cnp1wt/wt mice. mRNA abundance of Sept8 was decreased to about 30% in 
COND compared to WT. The remaining Sept8 mRNA was likely the product of cells other 
than oligodendrocytes since the prepared corpus callosum also contains astrocytes, 
microglia and few cortical neurons. The mRNA abundance of Sept2, Sept4, Sept7, Sept9 
and Anln was tested. The abundance of none of the corresponding mRNAs was altered in 
COND mice. This suggested that the loss of septins in CNS myelin of SEPT8 deficient 






Fig. 10. Post-translational loss of myelin septins when SEPT8 is lacking. A Protein 
abundance in SEPT8-deficient myelin was compared to controls. SEPT2, SEPT4, SEPT7 and 
SEPT9 were readily detected in control myelin (WT), but were strongly diminished in conditional 
(COND) and constitutive (KO) mutant myelin. In contrast, the abundance of SEPT11 was 
unchanged. B Quantitative mass spectrometry was performed to compare control (WT, n=3) and 
constitutive myelin (KO, n=3). Only 5 proteins were found to be decreased to an abundance of 
below 50%, namely the myelin septins and a known protein to interact with them, anillin (error bar: 
SEM, *** p<0.001). C qRT-PCR analysis of mRNAs encoding septins and anillin. In the corpus 
callosum of WT and COND (each n=4), only Sept8 mRNA was changed due to the genetic 
modification, indicating that the observed protein abundance changes were due to alterations at the 
post-transcriptional level (error bar: SEM, *** p<0.001). D The abundance of septins was analyzed 
in brain lysates and myelin purified from SEPT4 deficient mice. The abundance of SEPT2 was 







Since SEPT8 was required for other septins to be present in the CNS myelin, we aimed to 
test, if all septins affect each other equally. SEPT4-deficient mice (Kissel et al., 2005) 
were available from H.Steller (NewYork). Comparing control mice (WT) and constitutive 
mutant mice of SEPT4 (KO) by immunoblot, it was found that the abundance of SEPT2 
was about doubled in SEPT4 deficient myelin (Fig. 10D). This change was also apparent 
in the brain lysate. In contrast, the abundance of SEPT8 was unchanged in SEPT4 
mutants. The loss of SEPT4 did thus not lead to a loss of septins in CNS myelin. CNP 
was used here as a loading control and to validate myelin enrichment. Immunoblot 
experiments were performed with technical support by the bachelor student Nicole 
Bartsch.  
 
Taken together, SEPT8 was deleted from CNS myelin of mice and here it was shown that 
this led to the additional loss of all abundant myelin septins. Hence, it was hypothesized 
that SEPT8-deficient mice could be used to study the functional requirement of septin 
filaments in adaxonal myelin. 
 
4.2.3. SEPT8 deficient mice - development and behavior 
Conditional and constitutive SEPT8-mutants were observed from birth up to an age of one 
and a half years. Mutants of both genotypes were born in Mendelian ratio and developed 
normally. Pups grew as control littermates; they were never smaller or died prematurely. 
Constitutive males and females reproduced well and produced normal sized litters. The 
weight of the animals was compared at four months and one year of age (Fig. 11A). 
Young adult conditional (COND) and constitutive mutants (KO) had the same weight as 
the controls (WT). At one year of age WT and COND mice equally gained weight. 
Conversely, KO mice gained less weight and were significantly lighter than WT and 
COND at one year of age. KO mice gained about 17% less weight, which may hint to a 
role of SEPT8 in the metabolism of mice. The loss of SEPT8 from oligodendrocytes did 
not lead to apparent impairments affecting the weight of mice. 
 
Conditional and constitutive SEPT8 mutants were subjected to coordination motor 
behavior tests. The elevated beam test was used (Brooks and Dunnett, 2009). In this task 
mice walk over a narrow beam and hind limb slips are counted (Fig. 11B). This test was 
performed with 6 animals per genotype at the age of half a year and repeated at one year. 
Mice of all genotypes showed a high variability and did not differ significantly at either time 







Comparing SEPT8 mutants to controls, the overall brain morphology was analyzed (Fig. 
12). The Gallyas silver impregnation method was used to visualize myelin (Gallyas, 1979). 
The brains of all genotypes and ages were equal in size and structure. The amount of 
myelin appeared equal. The loss of SEPT8 and the interacting septins in myelin did thus 
not impair the general development of myelin or the brain. 
 
 
Fig. 11. Weight and motor capabilities of SEPT8-mutant mice. A Animals were weighed at the 
ages of four months and one year (error bar: SEM). Young adult mice showed no difference 
between the genotypes. At one year of age, constitutive mutants (KO) were about 17% lighter than 
controls (WT) and conditional mutants (COND). B The elevated beam test was used to analyze 
motor capabilities (illustration taken from Brooks and Dunnett, 2009). C In this test, no differences 







Fig. 12. Brain structure and general myelination of SEPT8-mutant mice. Gallyas silver 
impregnation was used to analyze brain structure (Gallyas, 1979). Myelin was impregnated in 
brown. Control and SEPT8-mutant mice were impregnated at half a year or one year of age. The 










4.2.4. Pathological abnormalities of septin-deficient CNS myelin 
The deletion of SEPT8 expression led to mice that lacked septins from myelin. As myelin 
abnormalities might not lead to obvious changes in mouse behavior, the structure of 
myelin was analyzed in more detail. The optic nerves of P75 and half-year old mice were 
studied. By light microscopy, semi-thin sections of P75 optic nerves from SEPT8 mutant 
mice and controls were compared (Fig. 13A). Comparing WT and KO, myelin pathology 
was visible in the optic nerve of KO (Fig. 13A, red arrow head). By electron microscopy, 
this pathology was identified as myelin outfoldings and redundant myelin. The numbers of 
myelin outfoldings and redundant myelin loops were quantified. Conditional and 
constitutive mutants were similar at each time point tested. Both mutants displayed 
significantly more myelin abnormalities compared to WT. At P75, myelin outfoldings and 
redundant myelin were four times more abundant in COND and KO than in WT. These 
myelin abnormalities were progressive with age (Fig. 13B). Also in WT the number of 
myelin outfoldings increased with age, whereas redundant myelin did not. 
 
Nevertheless, many axonal segments displayed normal myelin. Myelin thickness was 
analyzed at these segments by measuring g-ratios (Fig. 14A). Apparently, myelin 
thickness was not changed, as revealed by the comparison between WT and COND. 
Hypermyelination was thus present exclusively as myelin outfoldings and redundant 
myelin. These structures accounted for 3 times more area of the optic nerve at P75. More 
area was occupied by myelin abnormalities at higher age (Fig. 14B). The loss of septins in 
adaxonal myelin thus led to myelin outfoldings and redundant myelin without a general 






Fig. 13. Myelin abnormalities when SEPT8 is lacking. A Semi-thin sections of optic nerves were 
prepared at P75. While control (WT) axons appeared normally myelinated, intensely labeled myelin 
structures (red arrowheads) were apparent in SEPT8 deficient mice (KO). B Optic nerves analyzed 
by EM revealed myelin outfoldings and redundant myelin. These structures were quantified (n=6 
per genotype, error bars: SD). The numbers of myelin outfoldings and redundant myelin loops were 
strongly increased in KO and COND compared to WT. KO and COND were equally affected. 
Comparing the ages of P75 and half a year, the numbers of myelin outfoldings and redundant 







Fig. 14. Myelin thickness and pathology in the optic nerve of SEPT8-mutant mice. A The 
myelin thickness of healthy-appearing axonal segments was analyzed by measuring the g-ratio. 
The myelin thickness was unchanged. A’ An illustration how the g-ratio was determined. B In 
contrast, hypermyelinated profiles such as outfoldings and redundant myelin occupied three times 
more area in COND and KO compared to WT mice at the age of P75, and four times more at half a 
year. The KO mutant displayed equal changes as COND (n=6 per genotype, error bars: SD, * 







4.2.5. Secondary neuropathological effects in SEPT8 deficient mice 
Mice that lack SEPT8 from oligodendrocytes developed myelin abnormalities. Here, the 
question was raised if outfoldings and redundant myelin affect the health of axons and the 
surrounding brain tissue. Therefore, mice at the age of half a year or one year were 
perfused and subjected to immunohistochemistry using neuropathological markers. 
Amyloid beta precursor protein (APP) is expressed by neurons and transported along 
axons (Zheng and Koo, 2006). In pathological situations, APP accumulates within axons 
and is a sign of axonal degeneration (Coleman, 2005, Saxena and Caroni, 2007). The 
fimbria, a white matter area of the brain, was studied to identify APP accumulations (Fig. 
15A). At the age of half a year no difference regarding APP accumulations was detected 
comparing WT and COND mice (Fig. 15B). At the age of one year, accumulations of APP 
were apparent in SEPT8 deficient mice (Fig. 15A and B). Hence, only upon aging SEPT8-
deficient mice developed moderate axonal pathology. Importantly, Cnp1cre/wt mice were 
used as a control group. In COND and Cnp1cre/wt, the abundance of CNP was reduced in 
myelin. Both groups equally showed signs of axonal pathology. Therefore, not the loss of 
SEPT8 but the reduced abundance of CNP in myelin affected axonal health. Axonal 
pathology was also seen in the constitutive SEPT8 mutants (KO). Since SEPT8 is also 
expressed by neurons, deficiency of neuronal SEPT8 could cause APP accumulations. 
Taken together, conditional and constitutive SEPT8 deficient mice did indeed display 
moderate axonal pathology, but septin loss from myelin and subsequent myelin 
abnormalities are not necessarily the cause.  
 
Microglia react to pathological changes in their environment and are able to phagocytose 
myelin debris (Cuzner et al., 1988, Mosley and Cuzner, 1996). In a pathological situation, 
microglia are activated, change into amoeboid cells and express the surface antigen 
MAC-3 (Ho and Springer, 1983, Giulian and Baker, 1986). MAC-3 was detected by 
immunohistochemistry and quantified in the fimbria (Fig. 16A). At the age of half a year, 
no differences between WT and COND were identified (Fig. 16B). MAC-3 positive 
microglia were detected only in COND at the age of one year (Fig. 16A and B). Hence, the 
loss of SEPT8 induced microglial activation only together with the reduced abundance of 
CNP in myelin and upon aging. Analysis of secondary neuropathology was performed with 






Fig. 15. Axonal pathology in SEPT8-deficient mice. A Amyloid beta precursor protein (APP) was 
labeled in brains of 1 year old mice. Accumulations of APP (arrowheads) were quantified in the 
white matter (fimbria) of mutant brains. B At half a year of age, no difference regarding the number 
of APP
+
 spheroids between WT and COND was found. At one year all analyzed mutants (KO, 
COND and Cnp1
cre/wt






Fig. 16. Inflammation in SEPT8-deficient mice. A MAC-3, a marker of activated microglia, was 
labeled in brains comparing control (WT) and mutants. The fimbria was analyzed quantitatively as 
a model of white matter. Considerable numbers of activated microglia were found in COND mice 
(arrow heads). B Activated microglia were quantified at half a year and one year of age. Only 
COND mice at one year of age showed a significant elevation of MAC-3 positive microglia (error 





It was apparent that only with an additional trigger such as reduction of the abundance of 
CNP, myelin changes in mice lacking SEPT8 led to microglial activation. On the other 
hand, it was possible that the deletion of SEPT8 in all cells of the brain might impair 
microglial activation. To approach this, the model of experimental autoimmune 
encephalomyelitis (EAE) was used to further study the role of SEPT8 in microglial 
activation. WT and KO mice were injected with MOG peptide 35-55 at the age of 14 
weeks and observed daily. Both groups developed symptoms of EAE, as walking deficits 
and hindlimb paralysis. At day 14 after injection, animals were sacrificed and 
immunolabeled for MAC-3, the marker of activated microglia (Fig. 17A). The lumbar part 
of the spinal cord was analyzed for activated microglia. In both WT and KO mice, 
activated microglia were apparent, suggesting that microglial activation is not impaired in 
SEPT8 constitutive mutants.  
  
More importantly, it was of interest if morphological changes of septin-deficient myelin led 
to a different course of EAE. EAE induction in mice led to a high variability of the disease 
course and no significant differences between the genotypes were found under the used 
experimental conditions. Comparing microglial activation between WT and KO at day 14 
post injection, MAC-3 labeling was increased in KO, but not significantly when comparing 
6 animals per genotype (Fig. 17B).  
 
Taken together, pathological analyses of SEPT8 deficient mice showed that myelin 
outfoldings do not induce obvious axonal pathology or inflammation per se. Only when 
further stressors such as the reduction of CNP or the induction of EAE were applied, 






Fig. 17. Inflammation after EAE induction in SEPT8-mutants. A MAC-3, the marker for 
activated microglia, was labeled in the lumbar spinal cord 14 days after EAE induction. Constitutive 
SEPT8 mutants displayed robust microglia activation. B Comparing WT and KO, MAC-3 positive 
area appeared moderately increased in mutants, but this did not reach significance. C The EAE 





4.3. Septins in peripheral myelin 
4.3.1. Localization of septins in Schwann cells 
Similar to CNS myelin (see above) septins are abundant proteins in peripheral myelin 
(Buser et al., 2009, Patzig et al., 2011). Schwann cells, the myelin forming cells of the 
peripheral nervous system, were subjected to immunohistochemistry to determine the 
localization of septins. Axons of sciatic nerves were separated and teased fibers were 
immuno- labeled for SEPT7 and SEPT9 (Fig. 18). Either septin was exclusively detected 
in the abaxonal cytoplasmic channels of the Schwann cells, termed bands of Cajal. 
Hence, septin localization in peripheral myelin differed principally from that of CNS myelin.  
 
Fig. 18. Abaxonal localization of septins in peripheral myelin. SEPT7 and SEPT9 were labeled 
in preparations of single axons of the sciatic nerve (teased fibers). By confocal imaging, septins 






4.3.2. SEPT8 deficient Schwann cells 
CNP is a myelin protein also expressed by Schwann cells in the peripheral nerves 
(Sprinkle, 1989). Therefore the Cnp1-promotor driven expression of Cre recombinase did 
also lead to the deletion of SEPT8-expression in Schwann cells. Since SEPT8 loss in 
oligodendrocytes led to myelin abnormalities, myelin of the sciatic nerves was also 
analyzed. By light microscopy, semi-thin sections of sciatic nerves from half year old 
animals were studied (Fig. 19A). Myelin appeared normal in COND compared to WT. No 
changes such as outfoldings or redundant myelin were detected.  
By immunoblot, the abundance of septins in sciatic nerve lysates was studied (Fig. 19B). 
The abundance of SEPT8 was strongly decreased in the COND sciatic nerves, 
suggesting that most SEPT8, which was detectable in the sciatic nerves, was indeed 
expressed by Schwann cells. In KO nerves, all SEPT8 signal was lost. SEPT2, SEPT7 
and SEPT9 were detected in sciatic nerve lysates and none were diminished in COND or 
KO lysates. The abundance of SEPT2 and SEPT7 was quantified, and no significant 
change was identified (Fig. 19B). SEPT4 and SEPT6 were not detectable in sciatic 
nerves. SEPT11 was also detectable in the sciatic nerve lysates. In COND and KO 
nerves, the abundance of SEPT11 was found to be increased significantly suggesting the 
possibility of functional compensation (Fig. 19B). Immunoblot experiments were 






Fig. 19. Analysis of the PNS in SEPT8-deficient mice. A By light microscopy, semi-thin sections 
of sciatic nerves were analyzed in control (WT) and conditional SEPT8 mutants (COND) at half a 
year of age. No apparent difference was detected in myelin structure or thickness. B The 
abundance of septins was analyzed by immunoblot. The abundance of SEPT8 was strongly 
reduced in COND, and SEPT8 was undetectable in KO nerves. Other septins such as SEPT2, 
SEPT7, and SEPT9, were unchanged in abundance. The abundance of SEPT11 was significantly 








Myelin is a complex specialization of the plasma membrane of oligodendrocytes and 
Schwann cells important for fast nerve conduction. Furthermore, recent studies have 
shown that axonal integrity depends on functional myelinating glial cells (Nave, 2010). To 
uncover mechanisms important for the structural integrity of myelin, we and others have 
systematical analyzed its protein content. The work presented here characterizes the 
septin family of cytoskeletal proteins in myelin and its function in the maintenance of 
myelin integrity.  
 
5.1. Septins are abundant constituents of mature CNS myelin 
Previously, several studies have shown various septins as abundant constituents of CNS 
myelin in mice and humans using 2D-IEF/SDS-PAGE (Werner et al., 2007, Ishii et al., 
2009). We have now analyzed the protein content of myelin by gel-free LC-MSE. This 
method allows protein identification without previous gel separation and quantitative 
comparison of individual protein abundances (Jahn et al., 2013). Our results confirm that 
indeed SEPT2, SEPT4 and SEPT8 are abundant in CNS myelin of mice in agreement 
with immunoblot experiments (Fig. 4B) and prior studies (Werner et al., 2007, Buser et al., 
2009, Fewou et al., 2010). SEPT7 was newly detected as the second most abundant 
septin in myelin (Fig. 4C). The observed higher abundance of SEPT7 in brain lysates 
compared to myelin (Fig. 4B) is likely due to the proposed ubiquitous expression of 
SEPT7 (Kinoshita, 2003, Mostowy and Cossart, 2012). Thus, SEPT7 is a component of 
myelin, also not enriched. 
Based on quantitative gel-free MS and immunoblot, SEPT2, SEPT4, SEPT7 and SEPT8 
are constituents of CNS myelin. Septins are known to assemble into oligomers in a 1:1:1 
relationship. A 2/6/7-oligomer was previously described (Sheffield et al., 2003, Low and 
Macara, 2006, Sirajuddin et al., 2007) and it was suggested that homologous septins 
could replace one another in this oligomer (Kinoshita, 2003, Mostowy and Cossart, 2012). 
Considering the homology groups within the septin protein family, we suggest that in 
myelin SEPT8 takes the position of SEPT6 in the oligomer. SEPT2 and the related SEPT4 
together are about as abundant as SEPT8 and SEPT7. Hence, we predict myelin septin 






5.2. Reduced abundance of myelin septins in mouse mutants affecting   
 myelin-related genes 
The deletion of various myelin-related genes results in secondary axonal pathology. It has 
been hypothesized that oligodendroglial support of axons is impaired in these mutants 
(Nave, 2010). However, the underlying mechanism has not been identified. When 
systematically comparing the protein content of myelin purified from PLPnull and CNPnull 
mutants, the abundance of myelin septins was considerably decreased (Fig. 4D). We 
hypothesize that altered septin abundance is part of the observed pathology. In both 
mutants, various septins are not reduced to a similar level suggesting that the observed 
changes might be caused by different molecular upstream cascades. Future analysis may 
show if an additive effect leads to a further diminishment of myelin septins in mice lacking 
both PLP and CNP contributing to the observed enhanced neurological phenotype (Edgar 
et al., 2009).  
Several functions of septins are conceivable in myelin. Septins have been shown to be 
involved in vesicle transport and exocytosis (Dent et al., 2002, Gilden and Krummel, 2010, 
Yang et al., 2010). Speculatively, a reduced abundance of myelin septins might influence 
the secretion of multivesicular bodies / exosomes toward the axon. If these vesicles 
contain molecules important for axonal function (Kramer-Albers et al., 2007), their 
deficiency might lead to axonal pathologies as observed in PLPnull and CNPnull mice. 
Furthermore, septins influence membrane rigidity and act as diffusion barriers (Hall and 
Russell, 2012, Spiliotis and Gladfelter, 2012). Hence, septins could influence the integrity 
of myelin, which might be also relevant for axonal function. To increase the knowledge 
about the functional relevance of myelin septins, SEPT8 was deleted from 
oligodendrocytes by gene targeting. 
 
5.3. SEPT8 is essential for septin filament assembly in CNS myelin 
Secondarily to the deletion of SEPT8 in myelin, SEPT2, SEPT4, SEPT7, and SEPT9 were 
diminished (Fig. 10A). It was previously described in E.coli that septins were only stable 
upon the co-expression of at least two septin monomers of different homology groups 
(Sheffield et al., 2003). Additionally, in mammalian cell lines, it was shown that the 
presence of at least one member of the SEPT6-homology group (compare Fig. 20) is 
essential for oligomer formation (Sellin et al., 2011). Therefore, our data indicate that 
SEPT8 is essential for the formation of septin oligomers and/or filaments in myelin. 
Furthermore, it was shown that the effect of SEPT8-deficiency on other myelin septins is 





assemble into filaments in the adaxonal myelin compartment. Thereby, the loss of SEPT8 
likely leads to protein instability and degradation of the interaction partners.  
For SEPT9, only the 39kDa isoform was abundant in CNS myelin, and diminished in 
SEPT8- deficient myelin (Fig. 10A). It was recently suggested that this smallest splice 
isoform of SEPT9 might be the endpoint a filament (Kim et al., 2011). This is feasible 
since SEPT9 is of very low abundance when compared to other myelin septins. 
Furthermore, the loss of SEPT9 in SEPT8-deficient myelin confirms SEPT9 as an 
interaction partner of SEPT8, also considering double immunohistochemistry (Fig. 7B).  
The close homologs SEPT2 and SEPT4 are about equally abundant in CNS myelin (Fig. 
4C). To further understand filament assembly, the abundance of SEPT2 and SEPT8 was 
tested in SEPT4-deficient myelin (Fig. 10D). Whereas the abundance of SEPT8 was 
unchanged, the abundance of SEPT2 was about doubled. Redundancy within septin 
homology groups has been described for example in neurons, in which the abundance of 
SEPT2 was increased when SEPT5 was deleted (Peng et al., 2002). Interestingly, the 
deletion of SEPT4 led to septin dysfunction in sperm cells, in which the other homology 
group members SEPT2 or SEPT5 are not expressed (Kwitny et al., 2010). Hence, we 
assume that in myelin SEPT2 and SEPT4 may occupy the same position in the septin 
oligomer and may indeed be redundant (Fig. 20B).  
SEPT11 is a close homolog of SEPT8 (Fig. 20A). It has been predicted that homologs 
within the SEPT6 group may also occupy each other's position in the septin filament, 
provided they are expressed in the same cell (Kinoshita, 2003, Buser et al., 2009). In wild 
type and SEPT8-deficient myelin, the abundance of SEPT11 was not altered (Fig. 10A). 
Hence, there is no indication that SEPT11 would compensate for the loss of SEPT8 in 
CNS myelin. The biology of SEPT11 in myelinating glia and in other cells presently 







Fig. 20. Myelin septin filament assembly. A The biochemical and histological analyses of wild 
type and SEPT8-deficient myelin presented in this study indicate that SEPT2, SEPT4, SEPT7, 
SEPT8, and SEPT9 are abundant constituents of the internodal adaxonal myelin compartment. 
Thereby, at least one member of each of the four homology groups of septins has been identified 
(red arrows; phylogenetic tree taken from Buser et al., 2009). B Based on these findings and 
considering published literature on the assembly of septin filaments in various in vitro systems 
(Kinoshita, 2003, Nagata et al., 2004, Sirajuddin et al., 2007, Kim et al., 2011, Sellin et al., 2011, 
Hall and Russell, 2012), we propose the depicted model of the monomer composition of the septin 
filament in myelin in vivo. 
 
5.4. The presence of anillin in CNS myelin depends on septins  
Apart from the altered abundance of myelin septins, only one protein was diminished to 
below 50% in SEPT8-deficient myelin, namely anillin (Fig. 10B). Association of septins 
and anillin has been shown in several studies. For instance, anillin and septins co-localize 
at the cleavage furrow of yeast cells, in which they are essential for cell divisions 
(Oegema et al., 2000, Maddox et al., 2007). Furthermore, anillin was shown to enhance 
septin filament formation in vitro in dependence of the membrane lipid phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) (Kinoshita et al., 2002, Liu et al., 2012). Remarkably, our 
observations indicate an apparently reverse effect; the loss of septins led to a strongly 
decreased abundance of anillin in myelin. Since anillin is described as a positive regulator 
of the septin filament multimerization, and based on the unaltered mRNA abundance (Fig. 
10C), it is unlikely that the reduction is due to mechanisms involving transcriptional 
regulation. We thus suggest that anillin interacts with the septin filament in adaxonal 
myelin and is thereby stabilized. The proposed molecular interaction will be directly tested 






5.5. Septins localize to internodal adaxonal myelin  
We have newly identified a unique localization of myelin septins, which is a basis to 
uncover their function. We showed that septins assemble as filaments in the internodal 
adaxonal compartment of CNS myelin and thereby marked a novel subdomain (Fig. 6A 
and B). Proteins mediating glial-axonal interactions in the paranodal, juxtaparanodal, and 
nodal segments are well established (Poliak and Peles, 2003), but hardly any knowledge 
is available regarding the intercellular interactions in the internodal segment. However, as 
a large proportion of the axon is ensheathed by myelin a stabilizing cytoskeletal septin 
filaments might indeed affect myelinated axons. 
Not much is known about the molecular and structural organization of the internodal 
adaxonal membrane, which is relevant to be considered as septin cytoskeleton might also 
serve as a scaffold for important mediators of glial-axonal interaction and axonal integrity. 
This concept was tested by analyzing the abundance and localization affecting myelin-
associated glycoprotein (MAG), which is an abundant Ig-CAM localized to adaxonal 
myelin and the major marker of this membrane (Trapp and Quarles, 1982, Trapp et al., 
1989). We could show that septin loss did not affect its abundance or localization. By 
quantitative MS of SEPT8-deficient myelin, no proteins were altered in abundance that 
could be candidates to reside in adaxonal myelin. However, alterations of a protein's 
localization may not necessarily be revealed by the analysis of its abundance. For the 
proteins Caspr and Kv1.2, which were used to mark the paranodal and juxtaparanodal 
segments of axons respectively, no alteration in abundance or signal intensity were 
detected in SEPT8-defient mice by immunohistochemistry. Hence, the described changes 
of the localization of Caspr in CNPnull mice (Rasband et al., 2005) appear unrelated to the 
decreased septin abundance. Neurofascin155, a glial protein localizing to the paranodal 
segment (Zonta et al., 2008), was another candidate to rely on adaxonal septins for its 
subcellular localization. By immunohistochemistry, co-localization with Caspr was 
analyzed in SEPT8-defient mice; however no alterations were observed (data not shown).  
In summary, we identified the septin filament as a novel cytoskeletal component of 
internodal adaxonal myelin. We have speculated that myelin septins could potentially 
influence the localization of other proteins in adaxonal myelin. However, no such proteins 
were found, suggesting that any pathology observed in SEPT8-mutants at the cellular 





5.6. Mice lacking SEPT8 - development and behavior  
Conditional and constitutive SEPT8-mutants were observed from birth up to one and a 
half years of age. Several septins have been described to be essential in mammalian 
cytokinesis (Hall and Russell, 2004, Kremer et al., 2007, Fuchtbauer et al., 2011). The 
viability of constitutive SEPT8-mutants and the unimpaired breeding strongly suggest that 
SEPT8 is not critical for cell division.  
CNPnull and PLPnull mice show differences in pathology progression. Whereas CNPnull mice 
develop motor impairments already at an age of half a year, PLPnull show similiar 
abnormalities at about 16 months of age (Griffiths et al., 1998, Lappe-Siefke et al., 2003). 
SEPT8-deficient mice did not show comparable motor impairments (Fig. 11C) up to at 
least 18 months of age. The reduced weight of one year old constitutive SEPT8-mutants 
is unlikely to be related to oligodendrocyte function, according to control experiments in 
conditional mutants.  
Silver impregnation of myelin was used to evaluate the overall brain structure (Fig. 12). 
The size of hippocampus, cortex, ventricles and myelinated areas were comparable to 
controls at different ages. Hence, SEPT8 is not essential for general development and 
maintenance of the brain.  
 
5.7. Septin loss impairs the integrity of adaxonal myelin 
The expression of SEPT8 increases to detectable levels rather late in the development of 
mouse brains (>P15) and in a late stage of oligodendrocyte differentiation (Tsang et al., 
2011, de Monasterio-Schrader et al., 2012). Therefore, any effect of SEPT8 on the 
initiation of myelination was not to be expected. At P75, there were no obvious differences 
in the number of myelinated axons in the optic nerve (data not shown). Furthermore, 
myelin thickness was unchanged according to g-ratio (Fig. 14A). 
Interestingly, myelin pathology was frequent in mutant optic nerves (Fig. 13A). By EM, 
these changes were identified as myelin outfoldings and redundant myelin, which 
increased with age (Fig. 13B). Hence, SEPT8 and interacting myelin septins do not affect 
myelin thickness but myelin integrity. The localization of the septin filament in adaxonal 
myelin together with the structure of myelin outfoldings support the hypothesis that the 
pathology is due to diminished stabilization of the adaxonal myelin compartment. Mouse 
mutants lacking particular regulatory factors such as PTEN or CDC42 have also been 
reported to develop myelin outfoldings (Thurnherr et al., 2006, Goebbels et al., 2010). In 
contrast to these signaling proteins, septins can be considered endpoints of signal 





expression. We hypothesize that the loss of the septin filament from adaxonal myelin 
locally leads to myelin instability and therefore to the observed structural changes.   
Furthermore, it is theoretically possible to relate the structural myelin alterations in both, 
PTEN- or CDC42-deficient mice to a negative regulation of the septin filament. In PTEN-
mutant mice, Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) levels are diminished 
(Goebbels et al., 2010). Since it was demonstrated that PI(4,5)P2 is essential for higher 
order structures of septins (Tanaka-Takiguchi et al., 2009, Bertin et al., 2010), functional 
loss of septins in PTEN-deficient myelin is possible. The relevance of PI(4,5)P2 levels for 
myelin septins will be directly tested by future analysis of the abundance, localization, and 
extension of myelin septins in PTEN-mutant myelin. CDC42 has been shown to positively 
regulate the assembly of septin filaments by inhibiting their association with a protein 
family of septin assembly inhibitors, termed CDC42-effector proteins (cdc42ep) or binder 
of Rho GTPases (BORG) (Joberty et al., 2001). Thus, the observed myelin pathology 
upon deletion of PTEN or CDC42 could theoretically be explained by diminished septin 
filament assembly.   
Taken together, the observed loss of myelin integrity in SEPT8-mutants is likely a direct 
effect of septin loss in adaxonal myelin. Similar structural changes in other myelin mutants 
such as PTEN and CDC42 might also be related to negative regulation of the septin 
filament. Alterations in myelin structure of CNPnull and PLPnull mutants were also described 
(Griffiths et al., 1998, Edgar et al., 2009) and may well be related to a reduced abundance 







Fig. 21. Model of membrane association by myelin septins. A Septins polymerize dependent 
on the membrane lipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (Bertin et al., 2010, model 
adapted from Gilden et al., 2012). In similarity, myelin septins are hypothesized to elongate along 
PI(4,5)P2-rich domains of the myelin membrane to form a septin filament meshwork. B The septin 
cytoskeleton has been proposed to enhance membrane rigidity (Gilden et al., 2012). In agreement, 
myelin outfoldings may reflect diminished membrane rigidity of adaxonal myelin upon an 
impairment of functional myelin septin filaments. 
 
5.8. Secondary neuropathology in SEPT8-deficient mice 
PLP and CNP-deficient mice showed a reduction in the abundance of myelin septins (Fig. 
4D). In these mice, myelin is formed but axons degenerate (Griffiths et al., 1998, Lappe-
Siefke et al., 2003). We asked the question, if reduced septin abundance in myelin is part 
of the observed axonal degeneration. The accumulation of APP was used to analyze 
axonal pathology (Coleman, 2005, Saxena and Caroni, 2007). At the age of half a year, 
no axonal pathology was observed in SEPT8 conditional mice, as quantified in the fimbria 
(Fig. 15B). At this age, PLPnull and CNPnull mutants already display APP accumulations 
(Griffiths et al., 1998, Lappe-Siefke et al., 2003). Therefore, SEPT8-deficiency does not 
lead to the same early onset of axonal degeneration as PLPnull and CNPnull mutants.  
At the age of one year, conditional SEPT8-mutants, constitutive mutants and the 
additional control group Cnp1cre/wt showed equal numbers of APP accumulations whereas 
wild type controls had none. In Cnp1cre/wt and in conditional SEPT8 mutants the 
abundance of CNP in brain lysates and myelin was reduced to about 50% (Fig. 9B). 
Recently, this reduction was shown to cause a neurological pathology upon aging 
(Hagemeyer et al., 2012). In agreement with this report, we also found low numbers of 
APP accumulations. With that, similar numbers of APP accumulations in conditional 





low numbers of APP accumulations in constitutive SEPT8-mutants might be explained by 
SEPT8 functions in other cells, e.g. neurons. This could be tested in future experiments by 
recombining the Sept8-flox allele with a Cre-driver line for recombination in neurons, such 
as Nex-Cre mice. 
We note that the extent of axonal pathology identified in SEPT8-deficient mice is very 
moderate compared to PLPnull or CNPnull mice. Thus, the reduced abundance of septins 
and the subsequent emergence of myelin outfoldings do not cause axonal per se. Thus, 
these two aspects of neuropathology can be uncoupled in SEPT8-mutant mice. 
When microglial activation was analyzed, only conditional SEPT8-mutants displayed a 
significant number of MAC-3 positive microglia upon aging (Fig. 16A and B). By inducing 
experimental autoimmune encephalomyelitis (EAE), we could show that microglial cells in 
constitutive SEPT8-mutants are unlikely to be impaired (Fig. 17A). Therefore, we propose 
that myelin outfoldings in SEPT8-deficient myelin only causes mild inflammation when 
further triggered, e.g. by a reduction of CNP abundance. Hence, SEPT8 loss and the 
resulting myelin outfoldings can be viewed as a risk factor for an immune response in the 
brain.  
 
5.9. Influence of septin deficiency on the disease course of EAE 
Experimental autoimmune encephalomyelitis (EAE) is an animal model for particular 
aspects of the pathology in multiple sclerosis (Ransohoff, 2012). It is assumed that 
inflammation leads to demyelination in multiple sclerosis patients, but the causative agent 
has not been identified so far. Thus, it has been discussed that myelin damage may 
trigger the immune response in multiple sclerosis patients (Trapp and Nave, 2008). We 
have identified that SEPT8-deficiency together with reduced expression of CNP in 
oligodendrocytes activate microglia in the brain of mice. CNP reduction alone also triggers 
microglial activation upon aging (Hagemeyer et al., 2012). However, we showed that 
additional SEPT8 deficiency led to microglia activation to an earlier time point. Hence, we 
propose that the reduced abundance of CNP might induce microglial activation and that 
the structural changes affecting myelin as seen in SEPT8-mutant mice enhance the 
inflammation. 
To test this idea, we used the model of EAE to induce inflammation in constitutive SEPT8-
mutant mice. We ask if myelin outfoldings alter the progression of inflammation. In EAE, 
an autoimmune response is directed against a myelin protein (Rao and Segal, 2012). T-
cells and monocytes invade the CNS and induce an active attack of myelin by 





experimental set-up is necessary. We used 15-week-old mice, in which myelin outfoldings 
are already frequent. Indeed, SEPT8-deficient mice showed a trend to an enhanced EAE-
score and inflammation 14 days post injection, but not reaching significance. We analyzed 
14 days post injection as the peak of inflammation (Markoullis et al., 2012). In our 
experimental set-up, inflammation was already strong in control animals, which might 
have been a disadvantage for the detection of an increase in SEPT8-mutant mice. 
Therefore, a reduction of the administered dosis of pertussis toxin to sub-threshold 
induction and the analysis at an early post injection date might be more adequate to 
reveal a significant effect of myelin outfoldings on neuroinflammation.  
 
5.10. Biology of septins in peripheral myelin 
Oligodendrocytes and Schwann cells form myelin of a different ultrastructure. To 
approach the septin cytoskeleton also in peripheral nerves, the localization of SEPT7 and 
SEPT9 was analyzed by teased fiber preparations of sciatic nerves (Fig. 18). Both septins 
labeled abaxonal cytoplasmic channels of Schwann cells. Hence, septins showed a 
principally different localization in PNS myelin compared to CNS myelin, and it is thus 
likely that the exact function of septins is also different.  
Our recent proteomic analysis of peripheral myelin revealed SEPT2, SEPT7, SEPT9 and 
SEPT11 as abundant constituents (Patzig et al., 2011). By analyzing sciatic nerve lysates 
of wild type mice and constitutive SEPT8-mutants (Fig 19B), we additionally showed that 
also SEPT8 is expressed by Schwann cells. However, SEPT8-loss did not lead to myelin 
pathology or a secondary reduction of other septins as in CNS myelin. Interestingly, the 
abundance of SEPT11, a close homolog of SEPT8, was increased (Fig. 19B). Hence, our 
results suggest a possible functional redundancy of SEPT8 and SEPT11 in Schwann cells 
as it was previously predicted for close homologs (Kinoshita, 2003, Buser et al., 2009, 
Mostowy and Cossart, 2012). This could be tested in future experiments using mouse 
mutants lacking both, SEPT8 and SEPT11. 
The relevance of understanding septin biology in peripheral myelin is obvious when 
considering hereditary neuralgic amyotrophy (HNA). This neuropathy is associated with 
duplication or point mutations of the SEPT9-gene leading to episodes of multifocal paresis 
and sensory loss in patients (van Alfen, 2011). The SEPT9-gene is characterized by the 
emergence of multiple splice isoforms, which are likely to exert principally different 
functions in filament polymerization (Peterson and Petty, 2010, Kim et al., 2011). In wild 
type sciatic nerves of mice, the small 39kDa isoform was abundant and at least partially 





overexpression of SEPT9 in mice in various cell types might reveal pathomechanisms 
relevant in HNA.  
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